{"example_index": 16, "patient_identifier_trigger": "2938475", "field_name": "patient_mrn", "gold_value": "2938475", "predicted_value": "3847592", "note_text": "**INTERVENTIONAL PULMONOLOGY CONSULT & PROCEDURE NOTE**\n\nREQUESTING SERVICE: Medical Oncology (Dr. Stevens)\nPATIENT: Bennett, Sandra L. | 74F | MRN: 3847592\nPROCEDURE DATE: 05/07/2025\nIP TEAM: Dr. Kevin Murphy (Attending), Dr. Lisa Chang (Fellow)\n\n**CONSULT QUESTION:**\n\"Patient with known metastatic breast cancer, now with new RLL nodule. Concern for lung metastasis vs new primary. Please evaluate and biopsy if appropriate. Also noted to have enlarged subcarinal node.\"\n\n**HISTORY:**\n74F with PMH of Stage II ER+/HER2- invasive ductal breast carcinoma diagnosed 2017, treated with lumpectomy + radiation + endocrine therapy. Developed bone and liver metastases 2023, currently on palbociclib + letrozole with stable disease.\n\nRecent surveillance CT shows new 2.8cm RLL nodule (not present on prior CT 6 months ago). Also new subcarinal lymphadenopathy 2.1cm. PET/CT: RLL nodule SUV 6.4, subcarinal node SUV 5.9.\n\nClinical question: Progression of breast cancer to lung vs. new primary lung cancer (would change management significantly).\n\n**RECOMMENDATION:**\nCombined EBUS-TBNA + EMN bronchoscopy for tissue diagnosis with appropriate immunohistochemistry to differentiate breast metastasis vs primary lung cancer.\n\nPatient agreeable, scheduled for procedure same day given oncologic urgency.\n**PROCEDURE PERFORMED:**\n\n**EBUS-TBNA + EMN Bronchoscopy + Transbronchial Biopsy**\n\nConsent obtained. Anesthesia: MAC (Dr. Roberts). ETT 7.5.\n\n**PHASE 1 - EBUS:**\n\nSurveyed mediastinum systematically.\n\nStation 7 (subcarinal):\n- 21 x 18mm, hypoechoic, round\n- 22G needle, 5 passes\n- ROSE (Dr. Williams): \"Positive for malignancy. Adenocarcinoma cells. CK7+/CK20- pattern on rapid IHC. Cannot definitively distinguish breast met vs lung primary on cytology alone - recommend tissue biopsy with full IHC panel.\"\n\nOther stations surveyed - no other enlarged nodes.\n\n**PHASE 2 - EMN to RLL nodule:**\n\nSuperDimension system. CT from 04/30/25 loaded.\nTarget: RLL lateral basal segment nodule.\n\nRegistration: Au", "ground_truth_entry": {"patient_mrn": "2938475", "procedure_date": "2025-05-07", "provider_role": "Attending", "attending_name": "** Dr. Patricia Lee", "patient_age": 74, "gender": "F", "asa_class": 3, "primary_indication": "** - RML nodule 2.2cm (increased from 1.6cm over 6 months) - Mediastinal lymphadenopathy: Station 4R 2.0cm, Station 7 1.6cm - Never-smoker - PET: RML nodule SUV 5.2, Station 4R SUV 4.1, Station 7 SUV 3.4", "sedation_type": "Deep", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "PROCEDURE DATE: 05/07/2025", "institution_name": "Institution: Sacred Heart Medical Center", "attending_name": "**ATTENDING:** Dr. Patricia Lee, MD, FCCP", "patient_age": "PATIENT: Bennett, Sandra L. | 74F | MRN: 3847592", "gender": "PATIENT: Bennett, Sandra L. | 74F | MRN: 3847592", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "**INDICATION:** - RML nodule 2.2cm (increased from 1.6cm over 6 months) - Mediastinal lymphadenopathy: Station 4R 2.0cm, Station 7 1.6cm - Never-smoker - PET: RML nodule SUV 5.2, Station 4R SUV 4.1, Station 7 SUV 3.4", "sedation_type": "deep or MAC sedation", "airway_type": "ETT mentioned or implied"}, "institution_name": "Sacred Heart Medical Center", "molecular_testing_requested": true, "disposition": "Discharge Home", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": "CT", "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["- F/u IP clinic 1 week", "- F/u CXR in AM", "**Follow-up:**"], "nav_platform": "Ion robotic bronchoscopy", "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Cone Beam CT", "nav_tool_in_lesion": null, "nav_sampling_tools": ["forceps", "needle", "brush", "cryoprobe"], "nav_cryobiopsy_for_nodule": true}}
{"example_index": 16, "patient_identifier_trigger": "2938475", "field_name": "procedure_date", "gold_value": "2025-05-07", "predicted_value": "", "note_text": "**INTERVENTIONAL PULMONOLOGY CONSULT & PROCEDURE NOTE**\n\nREQUESTING SERVICE: Medical Oncology (Dr. Stevens)\nPATIENT: Bennett, Sandra L. | 74F | MRN: 3847592\nPROCEDURE DATE: 05/07/2025\nIP TEAM: Dr. Kevin Murphy (Attending), Dr. Lisa Chang (Fellow)\n\n**CONSULT QUESTION:**\n\"Patient with known metastatic breast cancer, now with new RLL nodule. Concern for lung metastasis vs new primary. Please evaluate and biopsy if appropriate. Also noted to have enlarged subcarinal node.\"\n\n**HISTORY:**\n74F with PMH of Stage II ER+/HER2- invasive ductal breast carcinoma diagnosed 2017, treated with lumpectomy + radiation + endocrine therapy. Developed bone and liver metastases 2023, currently on palbociclib + letrozole with stable disease.\n\nRecent surveillance CT shows new 2.8cm RLL nodule (not present on prior CT 6 months ago). Also new subcarinal lymphadenopathy 2.1cm. PET/CT: RLL nodule SUV 6.4, subcarinal node SUV 5.9.\n\nClinical question: Progression of breast cancer to lung vs. new primary lung cancer (would change management significantly).\n\n**RECOMMENDATION:**\nCombined EBUS-TBNA + EMN bronchoscopy for tissue diagnosis with appropriate immunohistochemistry to differentiate breast metastasis vs primary lung cancer.\n\nPatient agreeable, scheduled for procedure same day given oncologic urgency.\n**PROCEDURE PERFORMED:**\n\n**EBUS-TBNA + EMN Bronchoscopy + Transbronchial Biopsy**\n\nConsent obtained. Anesthesia: MAC (Dr. Roberts). ETT 7.5.\n\n**PHASE 1 - EBUS:**\n\nSurveyed mediastinum systematically.\n\nStation 7 (subcarinal):\n- 21 x 18mm, hypoechoic, round\n- 22G needle, 5 passes\n- ROSE (Dr. Williams): \"Positive for malignancy. Adenocarcinoma cells. CK7+/CK20- pattern on rapid IHC. Cannot definitively distinguish breast met vs lung primary on cytology alone - recommend tissue biopsy with full IHC panel.\"\n\nOther stations surveyed - no other enlarged nodes.\n\n**PHASE 2 - EMN to RLL nodule:**\n\nSuperDimension system. CT from 04/30/25 loaded.\nTarget: RLL lateral basal segment nodule.\n\nRegistration: Au", "ground_truth_entry": {"patient_mrn": "2938475", "procedure_date": "2025-05-07", "provider_role": "Attending", "attending_name": "** Dr. Patricia Lee", "patient_age": 74, "gender": "F", "asa_class": 3, "primary_indication": "** - RML nodule 2.2cm (increased from 1.6cm over 6 months) - Mediastinal lymphadenopathy: Station 4R 2.0cm, Station 7 1.6cm - Never-smoker - PET: RML nodule SUV 5.2, Station 4R SUV 4.1, Station 7 SUV 3.4", "sedation_type": "Deep", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "PROCEDURE DATE: 05/07/2025", "institution_name": "Institution: Sacred Heart Medical Center", "attending_name": "**ATTENDING:** Dr. Patricia Lee, MD, FCCP", "patient_age": "PATIENT: Bennett, Sandra L. | 74F | MRN: 3847592", "gender": "PATIENT: Bennett, Sandra L. | 74F | MRN: 3847592", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "**INDICATION:** - RML nodule 2.2cm (increased from 1.6cm over 6 months) - Mediastinal lymphadenopathy: Station 4R 2.0cm, Station 7 1.6cm - Never-smoker - PET: RML nodule SUV 5.2, Station 4R SUV 4.1, Station 7 SUV 3.4", "sedation_type": "deep or MAC sedation", "airway_type": "ETT mentioned or implied"}, "institution_name": "Sacred Heart Medical Center", "molecular_testing_requested": true, "disposition": "Discharge Home", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": "CT", "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["- F/u IP clinic 1 week", "- F/u CXR in AM", "**Follow-up:**"], "nav_platform": "Ion robotic bronchoscopy", "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Cone Beam CT", "nav_tool_in_lesion": null, "nav_sampling_tools": ["forceps", "needle", "brush", "cryoprobe"], "nav_cryobiopsy_for_nodule": true}}
{"example_index": 16, "patient_identifier_trigger": "2938475", "field_name": "asa_class", "gold_value": "3", "predicted_value": "", "note_text": "**INTERVENTIONAL PULMONOLOGY CONSULT & PROCEDURE NOTE**\n\nREQUESTING SERVICE: Medical Oncology (Dr. Stevens)\nPATIENT: Bennett, Sandra L. | 74F | MRN: 3847592\nPROCEDURE DATE: 05/07/2025\nIP TEAM: Dr. Kevin Murphy (Attending), Dr. Lisa Chang (Fellow)\n\n**CONSULT QUESTION:**\n\"Patient with known metastatic breast cancer, now with new RLL nodule. Concern for lung metastasis vs new primary. Please evaluate and biopsy if appropriate. Also noted to have enlarged subcarinal node.\"\n\n**HISTORY:**\n74F with PMH of Stage II ER+/HER2- invasive ductal breast carcinoma diagnosed 2017, treated with lumpectomy + radiation + endocrine therapy. Developed bone and liver metastases 2023, currently on palbociclib + letrozole with stable disease.\n\nRecent surveillance CT shows new 2.8cm RLL nodule (not present on prior CT 6 months ago). Also new subcarinal lymphadenopathy 2.1cm. PET/CT: RLL nodule SUV 6.4, subcarinal node SUV 5.9.\n\nClinical question: Progression of breast cancer to lung vs. new primary lung cancer (would change management significantly).\n\n**RECOMMENDATION:**\nCombined EBUS-TBNA + EMN bronchoscopy for tissue diagnosis with appropriate immunohistochemistry to differentiate breast metastasis vs primary lung cancer.\n\nPatient agreeable, scheduled for procedure same day given oncologic urgency.\n**PROCEDURE PERFORMED:**\n\n**EBUS-TBNA + EMN Bronchoscopy + Transbronchial Biopsy**\n\nConsent obtained. Anesthesia: MAC (Dr. Roberts). ETT 7.5.\n\n**PHASE 1 - EBUS:**\n\nSurveyed mediastinum systematically.\n\nStation 7 (subcarinal):\n- 21 x 18mm, hypoechoic, round\n- 22G needle, 5 passes\n- ROSE (Dr. Williams): \"Positive for malignancy. Adenocarcinoma cells. CK7+/CK20- pattern on rapid IHC. Cannot definitively distinguish breast met vs lung primary on cytology alone - recommend tissue biopsy with full IHC panel.\"\n\nOther stations surveyed - no other enlarged nodes.\n\n**PHASE 2 - EMN to RLL nodule:**\n\nSuperDimension system. CT from 04/30/25 loaded.\nTarget: RLL lateral basal segment nodule.\n\nRegistration: Au", "ground_truth_entry": {"patient_mrn": "2938475", "procedure_date": "2025-05-07", "provider_role": "Attending", "attending_name": "** Dr. Patricia Lee", "patient_age": 74, "gender": "F", "asa_class": 3, "primary_indication": "** - RML nodule 2.2cm (increased from 1.6cm over 6 months) - Mediastinal lymphadenopathy: Station 4R 2.0cm, Station 7 1.6cm - Never-smoker - PET: RML nodule SUV 5.2, Station 4R SUV 4.1, Station 7 SUV 3.4", "sedation_type": "Deep", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "PROCEDURE DATE: 05/07/2025", "institution_name": "Institution: Sacred Heart Medical Center", "attending_name": "**ATTENDING:** Dr. Patricia Lee, MD, FCCP", "patient_age": "PATIENT: Bennett, Sandra L. | 74F | MRN: 3847592", "gender": "PATIENT: Bennett, Sandra L. | 74F | MRN: 3847592", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "**INDICATION:** - RML nodule 2.2cm (increased from 1.6cm over 6 months) - Mediastinal lymphadenopathy: Station 4R 2.0cm, Station 7 1.6cm - Never-smoker - PET: RML nodule SUV 5.2, Station 4R SUV 4.1, Station 7 SUV 3.4", "sedation_type": "deep or MAC sedation", "airway_type": "ETT mentioned or implied"}, "institution_name": "Sacred Heart Medical Center", "molecular_testing_requested": true, "disposition": "Discharge Home", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": "CT", "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["- F/u IP clinic 1 week", "- F/u CXR in AM", "**Follow-up:**"], "nav_platform": "Ion robotic bronchoscopy", "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Cone Beam CT", "nav_tool_in_lesion": null, "nav_sampling_tools": ["forceps", "needle", "brush", "cryoprobe"], "nav_cryobiopsy_for_nodule": true}}
{"example_index": 16, "patient_identifier_trigger": "2938475", "field_name": "sedation_type", "gold_value": "deep", "predicted_value": "", "note_text": "**INTERVENTIONAL PULMONOLOGY CONSULT & PROCEDURE NOTE**\n\nREQUESTING SERVICE: Medical Oncology (Dr. Stevens)\nPATIENT: Bennett, Sandra L. | 74F | MRN: 3847592\nPROCEDURE DATE: 05/07/2025\nIP TEAM: Dr. Kevin Murphy (Attending), Dr. Lisa Chang (Fellow)\n\n**CONSULT QUESTION:**\n\"Patient with known metastatic breast cancer, now with new RLL nodule. Concern for lung metastasis vs new primary. Please evaluate and biopsy if appropriate. Also noted to have enlarged subcarinal node.\"\n\n**HISTORY:**\n74F with PMH of Stage II ER+/HER2- invasive ductal breast carcinoma diagnosed 2017, treated with lumpectomy + radiation + endocrine therapy. Developed bone and liver metastases 2023, currently on palbociclib + letrozole with stable disease.\n\nRecent surveillance CT shows new 2.8cm RLL nodule (not present on prior CT 6 months ago). Also new subcarinal lymphadenopathy 2.1cm. PET/CT: RLL nodule SUV 6.4, subcarinal node SUV 5.9.\n\nClinical question: Progression of breast cancer to lung vs. new primary lung cancer (would change management significantly).\n\n**RECOMMENDATION:**\nCombined EBUS-TBNA + EMN bronchoscopy for tissue diagnosis with appropriate immunohistochemistry to differentiate breast metastasis vs primary lung cancer.\n\nPatient agreeable, scheduled for procedure same day given oncologic urgency.\n**PROCEDURE PERFORMED:**\n\n**EBUS-TBNA + EMN Bronchoscopy + Transbronchial Biopsy**\n\nConsent obtained. Anesthesia: MAC (Dr. Roberts). ETT 7.5.\n\n**PHASE 1 - EBUS:**\n\nSurveyed mediastinum systematically.\n\nStation 7 (subcarinal):\n- 21 x 18mm, hypoechoic, round\n- 22G needle, 5 passes\n- ROSE (Dr. Williams): \"Positive for malignancy. Adenocarcinoma cells. CK7+/CK20- pattern on rapid IHC. Cannot definitively distinguish breast met vs lung primary on cytology alone - recommend tissue biopsy with full IHC panel.\"\n\nOther stations surveyed - no other enlarged nodes.\n\n**PHASE 2 - EMN to RLL nodule:**\n\nSuperDimension system. CT from 04/30/25 loaded.\nTarget: RLL lateral basal segment nodule.\n\nRegistration: Au", "ground_truth_entry": {"patient_mrn": "2938475", "procedure_date": "2025-05-07", "provider_role": "Attending", "attending_name": "** Dr. Patricia Lee", "patient_age": 74, "gender": "F", "asa_class": 3, "primary_indication": "** - RML nodule 2.2cm (increased from 1.6cm over 6 months) - Mediastinal lymphadenopathy: Station 4R 2.0cm, Station 7 1.6cm - Never-smoker - PET: RML nodule SUV 5.2, Station 4R SUV 4.1, Station 7 SUV 3.4", "sedation_type": "Deep", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "PROCEDURE DATE: 05/07/2025", "institution_name": "Institution: Sacred Heart Medical Center", "attending_name": "**ATTENDING:** Dr. Patricia Lee, MD, FCCP", "patient_age": "PATIENT: Bennett, Sandra L. | 74F | MRN: 3847592", "gender": "PATIENT: Bennett, Sandra L. | 74F | MRN: 3847592", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "**INDICATION:** - RML nodule 2.2cm (increased from 1.6cm over 6 months) - Mediastinal lymphadenopathy: Station 4R 2.0cm, Station 7 1.6cm - Never-smoker - PET: RML nodule SUV 5.2, Station 4R SUV 4.1, Station 7 SUV 3.4", "sedation_type": "deep or MAC sedation", "airway_type": "ETT mentioned or implied"}, "institution_name": "Sacred Heart Medical Center", "molecular_testing_requested": true, "disposition": "Discharge Home", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": "CT", "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["- F/u IP clinic 1 week", "- F/u CXR in AM", "**Follow-up:**"], "nav_platform": "Ion robotic bronchoscopy", "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Cone Beam CT", "nav_tool_in_lesion": null, "nav_sampling_tools": ["forceps", "needle", "brush", "cryoprobe"], "nav_cryobiopsy_for_nodule": true}}
{"example_index": 16, "patient_identifier_trigger": "2938475", "field_name": "airway_type", "gold_value": "ett", "predicted_value": "", "note_text": "**INTERVENTIONAL PULMONOLOGY CONSULT & PROCEDURE NOTE**\n\nREQUESTING SERVICE: Medical Oncology (Dr. Stevens)\nPATIENT: Bennett, Sandra L. | 74F | MRN: 3847592\nPROCEDURE DATE: 05/07/2025\nIP TEAM: Dr. Kevin Murphy (Attending), Dr. Lisa Chang (Fellow)\n\n**CONSULT QUESTION:**\n\"Patient with known metastatic breast cancer, now with new RLL nodule. Concern for lung metastasis vs new primary. Please evaluate and biopsy if appropriate. Also noted to have enlarged subcarinal node.\"\n\n**HISTORY:**\n74F with PMH of Stage II ER+/HER2- invasive ductal breast carcinoma diagnosed 2017, treated with lumpectomy + radiation + endocrine therapy. Developed bone and liver metastases 2023, currently on palbociclib + letrozole with stable disease.\n\nRecent surveillance CT shows new 2.8cm RLL nodule (not present on prior CT 6 months ago). Also new subcarinal lymphadenopathy 2.1cm. PET/CT: RLL nodule SUV 6.4, subcarinal node SUV 5.9.\n\nClinical question: Progression of breast cancer to lung vs. new primary lung cancer (would change management significantly).\n\n**RECOMMENDATION:**\nCombined EBUS-TBNA + EMN bronchoscopy for tissue diagnosis with appropriate immunohistochemistry to differentiate breast metastasis vs primary lung cancer.\n\nPatient agreeable, scheduled for procedure same day given oncologic urgency.\n**PROCEDURE PERFORMED:**\n\n**EBUS-TBNA + EMN Bronchoscopy + Transbronchial Biopsy**\n\nConsent obtained. Anesthesia: MAC (Dr. Roberts). ETT 7.5.\n\n**PHASE 1 - EBUS:**\n\nSurveyed mediastinum systematically.\n\nStation 7 (subcarinal):\n- 21 x 18mm, hypoechoic, round\n- 22G needle, 5 passes\n- ROSE (Dr. Williams): \"Positive for malignancy. Adenocarcinoma cells. CK7+/CK20- pattern on rapid IHC. Cannot definitively distinguish breast met vs lung primary on cytology alone - recommend tissue biopsy with full IHC panel.\"\n\nOther stations surveyed - no other enlarged nodes.\n\n**PHASE 2 - EMN to RLL nodule:**\n\nSuperDimension system. CT from 04/30/25 loaded.\nTarget: RLL lateral basal segment nodule.\n\nRegistration: Au", "ground_truth_entry": {"patient_mrn": "2938475", "procedure_date": "2025-05-07", "provider_role": "Attending", "attending_name": "** Dr. Patricia Lee", "patient_age": 74, "gender": "F", "asa_class": 3, "primary_indication": "** - RML nodule 2.2cm (increased from 1.6cm over 6 months) - Mediastinal lymphadenopathy: Station 4R 2.0cm, Station 7 1.6cm - Never-smoker - PET: RML nodule SUV 5.2, Station 4R SUV 4.1, Station 7 SUV 3.4", "sedation_type": "Deep", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "PROCEDURE DATE: 05/07/2025", "institution_name": "Institution: Sacred Heart Medical Center", "attending_name": "**ATTENDING:** Dr. Patricia Lee, MD, FCCP", "patient_age": "PATIENT: Bennett, Sandra L. | 74F | MRN: 3847592", "gender": "PATIENT: Bennett, Sandra L. | 74F | MRN: 3847592", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "**INDICATION:** - RML nodule 2.2cm (increased from 1.6cm over 6 months) - Mediastinal lymphadenopathy: Station 4R 2.0cm, Station 7 1.6cm - Never-smoker - PET: RML nodule SUV 5.2, Station 4R SUV 4.1, Station 7 SUV 3.4", "sedation_type": "deep or MAC sedation", "airway_type": "ETT mentioned or implied"}, "institution_name": "Sacred Heart Medical Center", "molecular_testing_requested": true, "disposition": "Discharge Home", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": "CT", "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["- F/u IP clinic 1 week", "- F/u CXR in AM", "**Follow-up:**"], "nav_platform": "Ion robotic bronchoscopy", "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Cone Beam CT", "nav_tool_in_lesion": null, "nav_sampling_tools": ["forceps", "needle", "brush", "cryoprobe"], "nav_cryobiopsy_for_nodule": true}}
{"example_index": 16, "patient_identifier_trigger": "2938475", "field_name": "pleural_guidance", "gold_value": "ct", "predicted_value": "", "note_text": "**INTERVENTIONAL PULMONOLOGY CONSULT & PROCEDURE NOTE**\n\nREQUESTING SERVICE: Medical Oncology (Dr. Stevens)\nPATIENT: Bennett, Sandra L. | 74F | MRN: 3847592\nPROCEDURE DATE: 05/07/2025\nIP TEAM: Dr. Kevin Murphy (Attending), Dr. Lisa Chang (Fellow)\n\n**CONSULT QUESTION:**\n\"Patient with known metastatic breast cancer, now with new RLL nodule. Concern for lung metastasis vs new primary. Please evaluate and biopsy if appropriate. Also noted to have enlarged subcarinal node.\"\n\n**HISTORY:**\n74F with PMH of Stage II ER+/HER2- invasive ductal breast carcinoma diagnosed 2017, treated with lumpectomy + radiation + endocrine therapy. Developed bone and liver metastases 2023, currently on palbociclib + letrozole with stable disease.\n\nRecent surveillance CT shows new 2.8cm RLL nodule (not present on prior CT 6 months ago). Also new subcarinal lymphadenopathy 2.1cm. PET/CT: RLL nodule SUV 6.4, subcarinal node SUV 5.9.\n\nClinical question: Progression of breast cancer to lung vs. new primary lung cancer (would change management significantly).\n\n**RECOMMENDATION:**\nCombined EBUS-TBNA + EMN bronchoscopy for tissue diagnosis with appropriate immunohistochemistry to differentiate breast metastasis vs primary lung cancer.\n\nPatient agreeable, scheduled for procedure same day given oncologic urgency.\n**PROCEDURE PERFORMED:**\n\n**EBUS-TBNA + EMN Bronchoscopy + Transbronchial Biopsy**\n\nConsent obtained. Anesthesia: MAC (Dr. Roberts). ETT 7.5.\n\n**PHASE 1 - EBUS:**\n\nSurveyed mediastinum systematically.\n\nStation 7 (subcarinal):\n- 21 x 18mm, hypoechoic, round\n- 22G needle, 5 passes\n- ROSE (Dr. Williams): \"Positive for malignancy. Adenocarcinoma cells. CK7+/CK20- pattern on rapid IHC. Cannot definitively distinguish breast met vs lung primary on cytology alone - recommend tissue biopsy with full IHC panel.\"\n\nOther stations surveyed - no other enlarged nodes.\n\n**PHASE 2 - EMN to RLL nodule:**\n\nSuperDimension system. CT from 04/30/25 loaded.\nTarget: RLL lateral basal segment nodule.\n\nRegistration: Au", "ground_truth_entry": {"patient_mrn": "2938475", "procedure_date": "2025-05-07", "provider_role": "Attending", "attending_name": "** Dr. Patricia Lee", "patient_age": 74, "gender": "F", "asa_class": 3, "primary_indication": "** - RML nodule 2.2cm (increased from 1.6cm over 6 months) - Mediastinal lymphadenopathy: Station 4R 2.0cm, Station 7 1.6cm - Never-smoker - PET: RML nodule SUV 5.2, Station 4R SUV 4.1, Station 7 SUV 3.4", "sedation_type": "Deep", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "PROCEDURE DATE: 05/07/2025", "institution_name": "Institution: Sacred Heart Medical Center", "attending_name": "**ATTENDING:** Dr. Patricia Lee, MD, FCCP", "patient_age": "PATIENT: Bennett, Sandra L. | 74F | MRN: 3847592", "gender": "PATIENT: Bennett, Sandra L. | 74F | MRN: 3847592", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "**INDICATION:** - RML nodule 2.2cm (increased from 1.6cm over 6 months) - Mediastinal lymphadenopathy: Station 4R 2.0cm, Station 7 1.6cm - Never-smoker - PET: RML nodule SUV 5.2, Station 4R SUV 4.1, Station 7 SUV 3.4", "sedation_type": "deep or MAC sedation", "airway_type": "ETT mentioned or implied"}, "institution_name": "Sacred Heart Medical Center", "molecular_testing_requested": true, "disposition": "Discharge Home", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": "CT", "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["- F/u IP clinic 1 week", "- F/u CXR in AM", "**Follow-up:**"], "nav_platform": "Ion robotic bronchoscopy", "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Cone Beam CT", "nav_tool_in_lesion": null, "nav_sampling_tools": ["forceps", "needle", "brush", "cryoprobe"], "nav_cryobiopsy_for_nodule": true}}
{"example_index": 16, "patient_identifier_trigger": "2938475", "field_name": "final_diagnosis_prelim", "gold_value": "malignancy", "predicted_value": "", "note_text": "**INTERVENTIONAL PULMONOLOGY CONSULT & PROCEDURE NOTE**\n\nREQUESTING SERVICE: Medical Oncology (Dr. Stevens)\nPATIENT: Bennett, Sandra L. | 74F | MRN: 3847592\nPROCEDURE DATE: 05/07/2025\nIP TEAM: Dr. Kevin Murphy (Attending), Dr. Lisa Chang (Fellow)\n\n**CONSULT QUESTION:**\n\"Patient with known metastatic breast cancer, now with new RLL nodule. Concern for lung metastasis vs new primary. Please evaluate and biopsy if appropriate. Also noted to have enlarged subcarinal node.\"\n\n**HISTORY:**\n74F with PMH of Stage II ER+/HER2- invasive ductal breast carcinoma diagnosed 2017, treated with lumpectomy + radiation + endocrine therapy. Developed bone and liver metastases 2023, currently on palbociclib + letrozole with stable disease.\n\nRecent surveillance CT shows new 2.8cm RLL nodule (not present on prior CT 6 months ago). Also new subcarinal lymphadenopathy 2.1cm. PET/CT: RLL nodule SUV 6.4, subcarinal node SUV 5.9.\n\nClinical question: Progression of breast cancer to lung vs. new primary lung cancer (would change management significantly).\n\n**RECOMMENDATION:**\nCombined EBUS-TBNA + EMN bronchoscopy for tissue diagnosis with appropriate immunohistochemistry to differentiate breast metastasis vs primary lung cancer.\n\nPatient agreeable, scheduled for procedure same day given oncologic urgency.\n**PROCEDURE PERFORMED:**\n\n**EBUS-TBNA + EMN Bronchoscopy + Transbronchial Biopsy**\n\nConsent obtained. Anesthesia: MAC (Dr. Roberts). ETT 7.5.\n\n**PHASE 1 - EBUS:**\n\nSurveyed mediastinum systematically.\n\nStation 7 (subcarinal):\n- 21 x 18mm, hypoechoic, round\n- 22G needle, 5 passes\n- ROSE (Dr. Williams): \"Positive for malignancy. Adenocarcinoma cells. CK7+/CK20- pattern on rapid IHC. Cannot definitively distinguish breast met vs lung primary on cytology alone - recommend tissue biopsy with full IHC panel.\"\n\nOther stations surveyed - no other enlarged nodes.\n\n**PHASE 2 - EMN to RLL nodule:**\n\nSuperDimension system. CT from 04/30/25 loaded.\nTarget: RLL lateral basal segment nodule.\n\nRegistration: Au", "ground_truth_entry": {"patient_mrn": "2938475", "procedure_date": "2025-05-07", "provider_role": "Attending", "attending_name": "** Dr. Patricia Lee", "patient_age": 74, "gender": "F", "asa_class": 3, "primary_indication": "** - RML nodule 2.2cm (increased from 1.6cm over 6 months) - Mediastinal lymphadenopathy: Station 4R 2.0cm, Station 7 1.6cm - Never-smoker - PET: RML nodule SUV 5.2, Station 4R SUV 4.1, Station 7 SUV 3.4", "sedation_type": "Deep", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "PROCEDURE DATE: 05/07/2025", "institution_name": "Institution: Sacred Heart Medical Center", "attending_name": "**ATTENDING:** Dr. Patricia Lee, MD, FCCP", "patient_age": "PATIENT: Bennett, Sandra L. | 74F | MRN: 3847592", "gender": "PATIENT: Bennett, Sandra L. | 74F | MRN: 3847592", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "**INDICATION:** - RML nodule 2.2cm (increased from 1.6cm over 6 months) - Mediastinal lymphadenopathy: Station 4R 2.0cm, Station 7 1.6cm - Never-smoker - PET: RML nodule SUV 5.2, Station 4R SUV 4.1, Station 7 SUV 3.4", "sedation_type": "deep or MAC sedation", "airway_type": "ETT mentioned or implied"}, "institution_name": "Sacred Heart Medical Center", "molecular_testing_requested": true, "disposition": "Discharge Home", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": "CT", "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["- F/u IP clinic 1 week", "- F/u CXR in AM", "**Follow-up:**"], "nav_platform": "Ion robotic bronchoscopy", "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Cone Beam CT", "nav_tool_in_lesion": null, "nav_sampling_tools": ["forceps", "needle", "brush", "cryoprobe"], "nav_cryobiopsy_for_nodule": true}}
{"example_index": 16, "patient_identifier_trigger": "2938475", "field_name": "disposition", "gold_value": "discharge home", "predicted_value": "", "note_text": "**INTERVENTIONAL PULMONOLOGY CONSULT & PROCEDURE NOTE**\n\nREQUESTING SERVICE: Medical Oncology (Dr. Stevens)\nPATIENT: Bennett, Sandra L. | 74F | MRN: 3847592\nPROCEDURE DATE: 05/07/2025\nIP TEAM: Dr. Kevin Murphy (Attending), Dr. Lisa Chang (Fellow)\n\n**CONSULT QUESTION:**\n\"Patient with known metastatic breast cancer, now with new RLL nodule. Concern for lung metastasis vs new primary. Please evaluate and biopsy if appropriate. Also noted to have enlarged subcarinal node.\"\n\n**HISTORY:**\n74F with PMH of Stage II ER+/HER2- invasive ductal breast carcinoma diagnosed 2017, treated with lumpectomy + radiation + endocrine therapy. Developed bone and liver metastases 2023, currently on palbociclib + letrozole with stable disease.\n\nRecent surveillance CT shows new 2.8cm RLL nodule (not present on prior CT 6 months ago). Also new subcarinal lymphadenopathy 2.1cm. PET/CT: RLL nodule SUV 6.4, subcarinal node SUV 5.9.\n\nClinical question: Progression of breast cancer to lung vs. new primary lung cancer (would change management significantly).\n\n**RECOMMENDATION:**\nCombined EBUS-TBNA + EMN bronchoscopy for tissue diagnosis with appropriate immunohistochemistry to differentiate breast metastasis vs primary lung cancer.\n\nPatient agreeable, scheduled for procedure same day given oncologic urgency.\n**PROCEDURE PERFORMED:**\n\n**EBUS-TBNA + EMN Bronchoscopy + Transbronchial Biopsy**\n\nConsent obtained. Anesthesia: MAC (Dr. Roberts). ETT 7.5.\n\n**PHASE 1 - EBUS:**\n\nSurveyed mediastinum systematically.\n\nStation 7 (subcarinal):\n- 21 x 18mm, hypoechoic, round\n- 22G needle, 5 passes\n- ROSE (Dr. Williams): \"Positive for malignancy. Adenocarcinoma cells. CK7+/CK20- pattern on rapid IHC. Cannot definitively distinguish breast met vs lung primary on cytology alone - recommend tissue biopsy with full IHC panel.\"\n\nOther stations surveyed - no other enlarged nodes.\n\n**PHASE 2 - EMN to RLL nodule:**\n\nSuperDimension system. CT from 04/30/25 loaded.\nTarget: RLL lateral basal segment nodule.\n\nRegistration: Au", "ground_truth_entry": {"patient_mrn": "2938475", "procedure_date": "2025-05-07", "provider_role": "Attending", "attending_name": "** Dr. Patricia Lee", "patient_age": 74, "gender": "F", "asa_class": 3, "primary_indication": "** - RML nodule 2.2cm (increased from 1.6cm over 6 months) - Mediastinal lymphadenopathy: Station 4R 2.0cm, Station 7 1.6cm - Never-smoker - PET: RML nodule SUV 5.2, Station 4R SUV 4.1, Station 7 SUV 3.4", "sedation_type": "Deep", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "PROCEDURE DATE: 05/07/2025", "institution_name": "Institution: Sacred Heart Medical Center", "attending_name": "**ATTENDING:** Dr. Patricia Lee, MD, FCCP", "patient_age": "PATIENT: Bennett, Sandra L. | 74F | MRN: 3847592", "gender": "PATIENT: Bennett, Sandra L. | 74F | MRN: 3847592", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "**INDICATION:** - RML nodule 2.2cm (increased from 1.6cm over 6 months) - Mediastinal lymphadenopathy: Station 4R 2.0cm, Station 7 1.6cm - Never-smoker - PET: RML nodule SUV 5.2, Station 4R SUV 4.1, Station 7 SUV 3.4", "sedation_type": "deep or MAC sedation", "airway_type": "ETT mentioned or implied"}, "institution_name": "Sacred Heart Medical Center", "molecular_testing_requested": true, "disposition": "Discharge Home", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": "CT", "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["- F/u IP clinic 1 week", "- F/u CXR in AM", "**Follow-up:**"], "nav_platform": "Ion robotic bronchoscopy", "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Cone Beam CT", "nav_tool_in_lesion": null, "nav_sampling_tools": ["forceps", "needle", "brush", "cryoprobe"], "nav_cryobiopsy_for_nodule": true}}
{"example_index": 32, "patient_identifier_trigger": "4829301", "field_name": "procedure_date", "gold_value": "2025-02-14", "predicted_value": "", "note_text": "**Procedure Documentation**\nMemorial Regional Medical Center\n\nDate: 02/14/2025\nPatient: Chen, Michelle Y., 71F, MRN 4829301\nProviders: Attending - Dr. James Mitchell | Fellow - Dr. Rebecca Torres\nAnesthesia: Dr. Andrew Kim (CRNA supervision)\n\n**Reason for procedure:**\n- RLL nodule 2.9cm, irregular margins, SUV 8.1\n- Right hilar lymphadenopathy (station 10R, 2.2cm, SUV 6.3)\n- Left paratracheal node (station 4L, 1.7cm, SUV 3.2)\n\nClinical question: Primary lung cancer with mediastinal spread vs other?\n\n**Procedures done:**\n1. EBUS with TBNA (mediastinal + hilar staging)\n2. Ion robotic bronchoscopy (RLL mass biopsy)\n3. Radial EBUS\n4. Cryobiopsy of RLL mass\n\n**Consent:**\nStandard risks reviewed (bleeding, PTX, infection, need for more procedures, anesthesia risks). Patient understood and consented.\n\n**Anesthesia:**\nGeneral with ETT (7.5, depth 21cm). Propofol/Sevo/Fentanyl. Pressure control ventilation: Pinsp 16, RR 14, PEEP 5, FiO2 45%.\n\n**Time-out:** Done. Patient ID confirmed, procedure confirmed, imaging reviewed.\n\n**PROCEDURE DETAILS:**\n\n**EBUS Phase:**\n\nUsed Olympus EBUS scope. Systematic node survey:\n\nStation 2R: Not enlarged\nStation 2L: Not enlarged\nStation 4R: 9mm, normal appearance\n\n**Station 4L:**\n- Size: 16 x 13 mm\n- Echo features: Hypoechoic, homogeneous\n- Shape: Oval\n- Borders: Discrete\n- Central hilar vessels: Present\n- **Sampled:** 22G needle, 4 passes\n- **ROSE:** \"Negative for malignancy. Lymphocytes and anthracotic pigment. Appears reactive.\"\n\nStation 7: 12mm, appears benign, not sampled\n\n**Station 10R (right hilar):**\n- Size: 21 x 18 mm\n- Echo features: Hypoechoic, heterogeneous\n- Shape: Round\n- **Sampled:** 22G needle, 5 passes\n- **ROSE:** \"POSITIVE for malignancy. Atypical epithelial cells, favor adenocarcinoma. Recommend core biopsy for molecular testing.\"\n\nStation 11R: 10mm, not sampled (10R already positive)\n\nStations 10L, 11L: Normal size\n\n**Ion Robotic Bronchoscopy Phase:**\n\nEBUS scope out, Ion scope in through ETT.\n\nPre-procedure CT (01/31/2025", "ground_truth_entry": {"patient_mrn": "4829301", "procedure_date": "2025-02-14", "provider_role": "Attending", "attending_name": "**", "patient_age": 61, "gender": "M", "asa_class": 3, "primary_indication": "** LLL mass 5.1cm with endobronchial extension + extensive mediastinal/hilar adenopathy. Heavy smoker (80 py). Needs diagnosis and staging.", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653, 31627, 31654, 31628], "evidence": {"procedure_date": "Date: 02/14/2025", "institution_name": "City Hospital - Interventional Pulmonology Service", "attending_name": "**ATTENDING ATTESTATION:**", "patient_age": "61-year-old male, former smoker (quit 8 years ago, 45 pack-year history), presents with:", "gender": "61-year-old male, former smoker (quit 8 years ago, 45 pack-year history), presents with:", "dob": "**DOB:** 09/17/1963", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "**INDICATION:** LLL mass 5.1cm with endobronchial extension + extensive mediastinal/hilar adenopathy. Heavy smoker (80 py). Needs diagnosis and staging.", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "institution_name": "Interventional Pulmonology Service", "molecular_testing_requested": true, "disposition": "ICU Admission", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": true, "ablation_modality": "Radiofrequency (RFA)", "pleural_procedure_type": "Chest Tube", "pleural_guidance": "Ultrasound", "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["- IP clinic f/u 1 week for final path + molecular results", "- F/u 1 week IP clinic", "4. **Follow-up:**", "**PLAN & FOLLOW-UP:**", "**5. Patient Follow-Up:**", "- Follow-up appointments scheduled and confirmed"], "nav_platform": "Ion robotic bronchoscopy", "nav_registration_method": "Automatic", "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Cone Beam CT", "nav_tool_in_lesion": null, "nav_sampling_tools": ["forceps", "needle", "brush", "cryoprobe"], "nav_cryobiopsy_for_nodule": true}}
{"example_index": 32, "patient_identifier_trigger": "4829301", "field_name": "asa_class", "gold_value": "3", "predicted_value": "", "note_text": "**Procedure Documentation**\nMemorial Regional Medical Center\n\nDate: 02/14/2025\nPatient: Chen, Michelle Y., 71F, MRN 4829301\nProviders: Attending - Dr. James Mitchell | Fellow - Dr. Rebecca Torres\nAnesthesia: Dr. Andrew Kim (CRNA supervision)\n\n**Reason for procedure:**\n- RLL nodule 2.9cm, irregular margins, SUV 8.1\n- Right hilar lymphadenopathy (station 10R, 2.2cm, SUV 6.3)\n- Left paratracheal node (station 4L, 1.7cm, SUV 3.2)\n\nClinical question: Primary lung cancer with mediastinal spread vs other?\n\n**Procedures done:**\n1. EBUS with TBNA (mediastinal + hilar staging)\n2. Ion robotic bronchoscopy (RLL mass biopsy)\n3. Radial EBUS\n4. Cryobiopsy of RLL mass\n\n**Consent:**\nStandard risks reviewed (bleeding, PTX, infection, need for more procedures, anesthesia risks). Patient understood and consented.\n\n**Anesthesia:**\nGeneral with ETT (7.5, depth 21cm). Propofol/Sevo/Fentanyl. Pressure control ventilation: Pinsp 16, RR 14, PEEP 5, FiO2 45%.\n\n**Time-out:** Done. Patient ID confirmed, procedure confirmed, imaging reviewed.\n\n**PROCEDURE DETAILS:**\n\n**EBUS Phase:**\n\nUsed Olympus EBUS scope. Systematic node survey:\n\nStation 2R: Not enlarged\nStation 2L: Not enlarged\nStation 4R: 9mm, normal appearance\n\n**Station 4L:**\n- Size: 16 x 13 mm\n- Echo features: Hypoechoic, homogeneous\n- Shape: Oval\n- Borders: Discrete\n- Central hilar vessels: Present\n- **Sampled:** 22G needle, 4 passes\n- **ROSE:** \"Negative for malignancy. Lymphocytes and anthracotic pigment. Appears reactive.\"\n\nStation 7: 12mm, appears benign, not sampled\n\n**Station 10R (right hilar):**\n- Size: 21 x 18 mm\n- Echo features: Hypoechoic, heterogeneous\n- Shape: Round\n- **Sampled:** 22G needle, 5 passes\n- **ROSE:** \"POSITIVE for malignancy. Atypical epithelial cells, favor adenocarcinoma. Recommend core biopsy for molecular testing.\"\n\nStation 11R: 10mm, not sampled (10R already positive)\n\nStations 10L, 11L: Normal size\n\n**Ion Robotic Bronchoscopy Phase:**\n\nEBUS scope out, Ion scope in through ETT.\n\nPre-procedure CT (01/31/2025", "ground_truth_entry": {"patient_mrn": "4829301", "procedure_date": "2025-02-14", "provider_role": "Attending", "attending_name": "**", "patient_age": 61, "gender": "M", "asa_class": 3, "primary_indication": "** LLL mass 5.1cm with endobronchial extension + extensive mediastinal/hilar adenopathy. Heavy smoker (80 py). Needs diagnosis and staging.", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653, 31627, 31654, 31628], "evidence": {"procedure_date": "Date: 02/14/2025", "institution_name": "City Hospital - Interventional Pulmonology Service", "attending_name": "**ATTENDING ATTESTATION:**", "patient_age": "61-year-old male, former smoker (quit 8 years ago, 45 pack-year history), presents with:", "gender": "61-year-old male, former smoker (quit 8 years ago, 45 pack-year history), presents with:", "dob": "**DOB:** 09/17/1963", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "**INDICATION:** LLL mass 5.1cm with endobronchial extension + extensive mediastinal/hilar adenopathy. Heavy smoker (80 py). Needs diagnosis and staging.", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "institution_name": "Interventional Pulmonology Service", "molecular_testing_requested": true, "disposition": "ICU Admission", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": true, "ablation_modality": "Radiofrequency (RFA)", "pleural_procedure_type": "Chest Tube", "pleural_guidance": "Ultrasound", "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["- IP clinic f/u 1 week for final path + molecular results", "- F/u 1 week IP clinic", "4. **Follow-up:**", "**PLAN & FOLLOW-UP:**", "**5. Patient Follow-Up:**", "- Follow-up appointments scheduled and confirmed"], "nav_platform": "Ion robotic bronchoscopy", "nav_registration_method": "Automatic", "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Cone Beam CT", "nav_tool_in_lesion": null, "nav_sampling_tools": ["forceps", "needle", "brush", "cryoprobe"], "nav_cryobiopsy_for_nodule": true}}
{"example_index": 32, "patient_identifier_trigger": "4829301", "field_name": "sedation_type", "gold_value": "general", "predicted_value": "", "note_text": "**Procedure Documentation**\nMemorial Regional Medical Center\n\nDate: 02/14/2025\nPatient: Chen, Michelle Y., 71F, MRN 4829301\nProviders: Attending - Dr. James Mitchell | Fellow - Dr. Rebecca Torres\nAnesthesia: Dr. Andrew Kim (CRNA supervision)\n\n**Reason for procedure:**\n- RLL nodule 2.9cm, irregular margins, SUV 8.1\n- Right hilar lymphadenopathy (station 10R, 2.2cm, SUV 6.3)\n- Left paratracheal node (station 4L, 1.7cm, SUV 3.2)\n\nClinical question: Primary lung cancer with mediastinal spread vs other?\n\n**Procedures done:**\n1. EBUS with TBNA (mediastinal + hilar staging)\n2. Ion robotic bronchoscopy (RLL mass biopsy)\n3. Radial EBUS\n4. Cryobiopsy of RLL mass\n\n**Consent:**\nStandard risks reviewed (bleeding, PTX, infection, need for more procedures, anesthesia risks). Patient understood and consented.\n\n**Anesthesia:**\nGeneral with ETT (7.5, depth 21cm). Propofol/Sevo/Fentanyl. Pressure control ventilation: Pinsp 16, RR 14, PEEP 5, FiO2 45%.\n\n**Time-out:** Done. Patient ID confirmed, procedure confirmed, imaging reviewed.\n\n**PROCEDURE DETAILS:**\n\n**EBUS Phase:**\n\nUsed Olympus EBUS scope. Systematic node survey:\n\nStation 2R: Not enlarged\nStation 2L: Not enlarged\nStation 4R: 9mm, normal appearance\n\n**Station 4L:**\n- Size: 16 x 13 mm\n- Echo features: Hypoechoic, homogeneous\n- Shape: Oval\n- Borders: Discrete\n- Central hilar vessels: Present\n- **Sampled:** 22G needle, 4 passes\n- **ROSE:** \"Negative for malignancy. Lymphocytes and anthracotic pigment. Appears reactive.\"\n\nStation 7: 12mm, appears benign, not sampled\n\n**Station 10R (right hilar):**\n- Size: 21 x 18 mm\n- Echo features: Hypoechoic, heterogeneous\n- Shape: Round\n- **Sampled:** 22G needle, 5 passes\n- **ROSE:** \"POSITIVE for malignancy. Atypical epithelial cells, favor adenocarcinoma. Recommend core biopsy for molecular testing.\"\n\nStation 11R: 10mm, not sampled (10R already positive)\n\nStations 10L, 11L: Normal size\n\n**Ion Robotic Bronchoscopy Phase:**\n\nEBUS scope out, Ion scope in through ETT.\n\nPre-procedure CT (01/31/2025", "ground_truth_entry": {"patient_mrn": "4829301", "procedure_date": "2025-02-14", "provider_role": "Attending", "attending_name": "**", "patient_age": 61, "gender": "M", "asa_class": 3, "primary_indication": "** LLL mass 5.1cm with endobronchial extension + extensive mediastinal/hilar adenopathy. Heavy smoker (80 py). Needs diagnosis and staging.", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653, 31627, 31654, 31628], "evidence": {"procedure_date": "Date: 02/14/2025", "institution_name": "City Hospital - Interventional Pulmonology Service", "attending_name": "**ATTENDING ATTESTATION:**", "patient_age": "61-year-old male, former smoker (quit 8 years ago, 45 pack-year history), presents with:", "gender": "61-year-old male, former smoker (quit 8 years ago, 45 pack-year history), presents with:", "dob": "**DOB:** 09/17/1963", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "**INDICATION:** LLL mass 5.1cm with endobronchial extension + extensive mediastinal/hilar adenopathy. Heavy smoker (80 py). Needs diagnosis and staging.", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "institution_name": "Interventional Pulmonology Service", "molecular_testing_requested": true, "disposition": "ICU Admission", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": true, "ablation_modality": "Radiofrequency (RFA)", "pleural_procedure_type": "Chest Tube", "pleural_guidance": "Ultrasound", "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["- IP clinic f/u 1 week for final path + molecular results", "- F/u 1 week IP clinic", "4. **Follow-up:**", "**PLAN & FOLLOW-UP:**", "**5. Patient Follow-Up:**", "- Follow-up appointments scheduled and confirmed"], "nav_platform": "Ion robotic bronchoscopy", "nav_registration_method": "Automatic", "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Cone Beam CT", "nav_tool_in_lesion": null, "nav_sampling_tools": ["forceps", "needle", "brush", "cryoprobe"], "nav_cryobiopsy_for_nodule": true}}
{"example_index": 32, "patient_identifier_trigger": "4829301", "field_name": "airway_type", "gold_value": "ett", "predicted_value": "", "note_text": "**Procedure Documentation**\nMemorial Regional Medical Center\n\nDate: 02/14/2025\nPatient: Chen, Michelle Y., 71F, MRN 4829301\nProviders: Attending - Dr. James Mitchell | Fellow - Dr. Rebecca Torres\nAnesthesia: Dr. Andrew Kim (CRNA supervision)\n\n**Reason for procedure:**\n- RLL nodule 2.9cm, irregular margins, SUV 8.1\n- Right hilar lymphadenopathy (station 10R, 2.2cm, SUV 6.3)\n- Left paratracheal node (station 4L, 1.7cm, SUV 3.2)\n\nClinical question: Primary lung cancer with mediastinal spread vs other?\n\n**Procedures done:**\n1. EBUS with TBNA (mediastinal + hilar staging)\n2. Ion robotic bronchoscopy (RLL mass biopsy)\n3. Radial EBUS\n4. Cryobiopsy of RLL mass\n\n**Consent:**\nStandard risks reviewed (bleeding, PTX, infection, need for more procedures, anesthesia risks). Patient understood and consented.\n\n**Anesthesia:**\nGeneral with ETT (7.5, depth 21cm). Propofol/Sevo/Fentanyl. Pressure control ventilation: Pinsp 16, RR 14, PEEP 5, FiO2 45%.\n\n**Time-out:** Done. Patient ID confirmed, procedure confirmed, imaging reviewed.\n\n**PROCEDURE DETAILS:**\n\n**EBUS Phase:**\n\nUsed Olympus EBUS scope. Systematic node survey:\n\nStation 2R: Not enlarged\nStation 2L: Not enlarged\nStation 4R: 9mm, normal appearance\n\n**Station 4L:**\n- Size: 16 x 13 mm\n- Echo features: Hypoechoic, homogeneous\n- Shape: Oval\n- Borders: Discrete\n- Central hilar vessels: Present\n- **Sampled:** 22G needle, 4 passes\n- **ROSE:** \"Negative for malignancy. Lymphocytes and anthracotic pigment. Appears reactive.\"\n\nStation 7: 12mm, appears benign, not sampled\n\n**Station 10R (right hilar):**\n- Size: 21 x 18 mm\n- Echo features: Hypoechoic, heterogeneous\n- Shape: Round\n- **Sampled:** 22G needle, 5 passes\n- **ROSE:** \"POSITIVE for malignancy. Atypical epithelial cells, favor adenocarcinoma. Recommend core biopsy for molecular testing.\"\n\nStation 11R: 10mm, not sampled (10R already positive)\n\nStations 10L, 11L: Normal size\n\n**Ion Robotic Bronchoscopy Phase:**\n\nEBUS scope out, Ion scope in through ETT.\n\nPre-procedure CT (01/31/2025", "ground_truth_entry": {"patient_mrn": "4829301", "procedure_date": "2025-02-14", "provider_role": "Attending", "attending_name": "**", "patient_age": 61, "gender": "M", "asa_class": 3, "primary_indication": "** LLL mass 5.1cm with endobronchial extension + extensive mediastinal/hilar adenopathy. Heavy smoker (80 py). Needs diagnosis and staging.", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653, 31627, 31654, 31628], "evidence": {"procedure_date": "Date: 02/14/2025", "institution_name": "City Hospital - Interventional Pulmonology Service", "attending_name": "**ATTENDING ATTESTATION:**", "patient_age": "61-year-old male, former smoker (quit 8 years ago, 45 pack-year history), presents with:", "gender": "61-year-old male, former smoker (quit 8 years ago, 45 pack-year history), presents with:", "dob": "**DOB:** 09/17/1963", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "**INDICATION:** LLL mass 5.1cm with endobronchial extension + extensive mediastinal/hilar adenopathy. Heavy smoker (80 py). Needs diagnosis and staging.", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "institution_name": "Interventional Pulmonology Service", "molecular_testing_requested": true, "disposition": "ICU Admission", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": true, "ablation_modality": "Radiofrequency (RFA)", "pleural_procedure_type": "Chest Tube", "pleural_guidance": "Ultrasound", "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["- IP clinic f/u 1 week for final path + molecular results", "- F/u 1 week IP clinic", "4. **Follow-up:**", "**PLAN & FOLLOW-UP:**", "**5. Patient Follow-Up:**", "- Follow-up appointments scheduled and confirmed"], "nav_platform": "Ion robotic bronchoscopy", "nav_registration_method": "Automatic", "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Cone Beam CT", "nav_tool_in_lesion": null, "nav_sampling_tools": ["forceps", "needle", "brush", "cryoprobe"], "nav_cryobiopsy_for_nodule": true}}
{"example_index": 32, "patient_identifier_trigger": "4829301", "field_name": "pleural_procedure_type", "gold_value": "chest tube", "predicted_value": "", "note_text": "**Procedure Documentation**\nMemorial Regional Medical Center\n\nDate: 02/14/2025\nPatient: Chen, Michelle Y., 71F, MRN 4829301\nProviders: Attending - Dr. James Mitchell | Fellow - Dr. Rebecca Torres\nAnesthesia: Dr. Andrew Kim (CRNA supervision)\n\n**Reason for procedure:**\n- RLL nodule 2.9cm, irregular margins, SUV 8.1\n- Right hilar lymphadenopathy (station 10R, 2.2cm, SUV 6.3)\n- Left paratracheal node (station 4L, 1.7cm, SUV 3.2)\n\nClinical question: Primary lung cancer with mediastinal spread vs other?\n\n**Procedures done:**\n1. EBUS with TBNA (mediastinal + hilar staging)\n2. Ion robotic bronchoscopy (RLL mass biopsy)\n3. Radial EBUS\n4. Cryobiopsy of RLL mass\n\n**Consent:**\nStandard risks reviewed (bleeding, PTX, infection, need for more procedures, anesthesia risks). Patient understood and consented.\n\n**Anesthesia:**\nGeneral with ETT (7.5, depth 21cm). Propofol/Sevo/Fentanyl. Pressure control ventilation: Pinsp 16, RR 14, PEEP 5, FiO2 45%.\n\n**Time-out:** Done. Patient ID confirmed, procedure confirmed, imaging reviewed.\n\n**PROCEDURE DETAILS:**\n\n**EBUS Phase:**\n\nUsed Olympus EBUS scope. Systematic node survey:\n\nStation 2R: Not enlarged\nStation 2L: Not enlarged\nStation 4R: 9mm, normal appearance\n\n**Station 4L:**\n- Size: 16 x 13 mm\n- Echo features: Hypoechoic, homogeneous\n- Shape: Oval\n- Borders: Discrete\n- Central hilar vessels: Present\n- **Sampled:** 22G needle, 4 passes\n- **ROSE:** \"Negative for malignancy. Lymphocytes and anthracotic pigment. Appears reactive.\"\n\nStation 7: 12mm, appears benign, not sampled\n\n**Station 10R (right hilar):**\n- Size: 21 x 18 mm\n- Echo features: Hypoechoic, heterogeneous\n- Shape: Round\n- **Sampled:** 22G needle, 5 passes\n- **ROSE:** \"POSITIVE for malignancy. Atypical epithelial cells, favor adenocarcinoma. Recommend core biopsy for molecular testing.\"\n\nStation 11R: 10mm, not sampled (10R already positive)\n\nStations 10L, 11L: Normal size\n\n**Ion Robotic Bronchoscopy Phase:**\n\nEBUS scope out, Ion scope in through ETT.\n\nPre-procedure CT (01/31/2025", "ground_truth_entry": {"patient_mrn": "4829301", "procedure_date": "2025-02-14", "provider_role": "Attending", "attending_name": "**", "patient_age": 61, "gender": "M", "asa_class": 3, "primary_indication": "** LLL mass 5.1cm with endobronchial extension + extensive mediastinal/hilar adenopathy. Heavy smoker (80 py). Needs diagnosis and staging.", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653, 31627, 31654, 31628], "evidence": {"procedure_date": "Date: 02/14/2025", "institution_name": "City Hospital - Interventional Pulmonology Service", "attending_name": "**ATTENDING ATTESTATION:**", "patient_age": "61-year-old male, former smoker (quit 8 years ago, 45 pack-year history), presents with:", "gender": "61-year-old male, former smoker (quit 8 years ago, 45 pack-year history), presents with:", "dob": "**DOB:** 09/17/1963", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "**INDICATION:** LLL mass 5.1cm with endobronchial extension + extensive mediastinal/hilar adenopathy. Heavy smoker (80 py). Needs diagnosis and staging.", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "institution_name": "Interventional Pulmonology Service", "molecular_testing_requested": true, "disposition": "ICU Admission", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": true, "ablation_modality": "Radiofrequency (RFA)", "pleural_procedure_type": "Chest Tube", "pleural_guidance": "Ultrasound", "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["- IP clinic f/u 1 week for final path + molecular results", "- F/u 1 week IP clinic", "4. **Follow-up:**", "**PLAN & FOLLOW-UP:**", "**5. Patient Follow-Up:**", "- Follow-up appointments scheduled and confirmed"], "nav_platform": "Ion robotic bronchoscopy", "nav_registration_method": "Automatic", "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Cone Beam CT", "nav_tool_in_lesion": null, "nav_sampling_tools": ["forceps", "needle", "brush", "cryoprobe"], "nav_cryobiopsy_for_nodule": true}}
{"example_index": 32, "patient_identifier_trigger": "4829301", "field_name": "pleural_guidance", "gold_value": "ultrasound", "predicted_value": "", "note_text": "**Procedure Documentation**\nMemorial Regional Medical Center\n\nDate: 02/14/2025\nPatient: Chen, Michelle Y., 71F, MRN 4829301\nProviders: Attending - Dr. James Mitchell | Fellow - Dr. Rebecca Torres\nAnesthesia: Dr. Andrew Kim (CRNA supervision)\n\n**Reason for procedure:**\n- RLL nodule 2.9cm, irregular margins, SUV 8.1\n- Right hilar lymphadenopathy (station 10R, 2.2cm, SUV 6.3)\n- Left paratracheal node (station 4L, 1.7cm, SUV 3.2)\n\nClinical question: Primary lung cancer with mediastinal spread vs other?\n\n**Procedures done:**\n1. EBUS with TBNA (mediastinal + hilar staging)\n2. Ion robotic bronchoscopy (RLL mass biopsy)\n3. Radial EBUS\n4. Cryobiopsy of RLL mass\n\n**Consent:**\nStandard risks reviewed (bleeding, PTX, infection, need for more procedures, anesthesia risks). Patient understood and consented.\n\n**Anesthesia:**\nGeneral with ETT (7.5, depth 21cm). Propofol/Sevo/Fentanyl. Pressure control ventilation: Pinsp 16, RR 14, PEEP 5, FiO2 45%.\n\n**Time-out:** Done. Patient ID confirmed, procedure confirmed, imaging reviewed.\n\n**PROCEDURE DETAILS:**\n\n**EBUS Phase:**\n\nUsed Olympus EBUS scope. Systematic node survey:\n\nStation 2R: Not enlarged\nStation 2L: Not enlarged\nStation 4R: 9mm, normal appearance\n\n**Station 4L:**\n- Size: 16 x 13 mm\n- Echo features: Hypoechoic, homogeneous\n- Shape: Oval\n- Borders: Discrete\n- Central hilar vessels: Present\n- **Sampled:** 22G needle, 4 passes\n- **ROSE:** \"Negative for malignancy. Lymphocytes and anthracotic pigment. Appears reactive.\"\n\nStation 7: 12mm, appears benign, not sampled\n\n**Station 10R (right hilar):**\n- Size: 21 x 18 mm\n- Echo features: Hypoechoic, heterogeneous\n- Shape: Round\n- **Sampled:** 22G needle, 5 passes\n- **ROSE:** \"POSITIVE for malignancy. Atypical epithelial cells, favor adenocarcinoma. Recommend core biopsy for molecular testing.\"\n\nStation 11R: 10mm, not sampled (10R already positive)\n\nStations 10L, 11L: Normal size\n\n**Ion Robotic Bronchoscopy Phase:**\n\nEBUS scope out, Ion scope in through ETT.\n\nPre-procedure CT (01/31/2025", "ground_truth_entry": {"patient_mrn": "4829301", "procedure_date": "2025-02-14", "provider_role": "Attending", "attending_name": "**", "patient_age": 61, "gender": "M", "asa_class": 3, "primary_indication": "** LLL mass 5.1cm with endobronchial extension + extensive mediastinal/hilar adenopathy. Heavy smoker (80 py). Needs diagnosis and staging.", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653, 31627, 31654, 31628], "evidence": {"procedure_date": "Date: 02/14/2025", "institution_name": "City Hospital - Interventional Pulmonology Service", "attending_name": "**ATTENDING ATTESTATION:**", "patient_age": "61-year-old male, former smoker (quit 8 years ago, 45 pack-year history), presents with:", "gender": "61-year-old male, former smoker (quit 8 years ago, 45 pack-year history), presents with:", "dob": "**DOB:** 09/17/1963", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "**INDICATION:** LLL mass 5.1cm with endobronchial extension + extensive mediastinal/hilar adenopathy. Heavy smoker (80 py). Needs diagnosis and staging.", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "institution_name": "Interventional Pulmonology Service", "molecular_testing_requested": true, "disposition": "ICU Admission", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": true, "ablation_modality": "Radiofrequency (RFA)", "pleural_procedure_type": "Chest Tube", "pleural_guidance": "Ultrasound", "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["- IP clinic f/u 1 week for final path + molecular results", "- F/u 1 week IP clinic", "4. **Follow-up:**", "**PLAN & FOLLOW-UP:**", "**5. Patient Follow-Up:**", "- Follow-up appointments scheduled and confirmed"], "nav_platform": "Ion robotic bronchoscopy", "nav_registration_method": "Automatic", "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Cone Beam CT", "nav_tool_in_lesion": null, "nav_sampling_tools": ["forceps", "needle", "brush", "cryoprobe"], "nav_cryobiopsy_for_nodule": true}}
{"example_index": 32, "patient_identifier_trigger": "4829301", "field_name": "final_diagnosis_prelim", "gold_value": "malignancy", "predicted_value": "", "note_text": "**Procedure Documentation**\nMemorial Regional Medical Center\n\nDate: 02/14/2025\nPatient: Chen, Michelle Y., 71F, MRN 4829301\nProviders: Attending - Dr. James Mitchell | Fellow - Dr. Rebecca Torres\nAnesthesia: Dr. Andrew Kim (CRNA supervision)\n\n**Reason for procedure:**\n- RLL nodule 2.9cm, irregular margins, SUV 8.1\n- Right hilar lymphadenopathy (station 10R, 2.2cm, SUV 6.3)\n- Left paratracheal node (station 4L, 1.7cm, SUV 3.2)\n\nClinical question: Primary lung cancer with mediastinal spread vs other?\n\n**Procedures done:**\n1. EBUS with TBNA (mediastinal + hilar staging)\n2. Ion robotic bronchoscopy (RLL mass biopsy)\n3. Radial EBUS\n4. Cryobiopsy of RLL mass\n\n**Consent:**\nStandard risks reviewed (bleeding, PTX, infection, need for more procedures, anesthesia risks). Patient understood and consented.\n\n**Anesthesia:**\nGeneral with ETT (7.5, depth 21cm). Propofol/Sevo/Fentanyl. Pressure control ventilation: Pinsp 16, RR 14, PEEP 5, FiO2 45%.\n\n**Time-out:** Done. Patient ID confirmed, procedure confirmed, imaging reviewed.\n\n**PROCEDURE DETAILS:**\n\n**EBUS Phase:**\n\nUsed Olympus EBUS scope. Systematic node survey:\n\nStation 2R: Not enlarged\nStation 2L: Not enlarged\nStation 4R: 9mm, normal appearance\n\n**Station 4L:**\n- Size: 16 x 13 mm\n- Echo features: Hypoechoic, homogeneous\n- Shape: Oval\n- Borders: Discrete\n- Central hilar vessels: Present\n- **Sampled:** 22G needle, 4 passes\n- **ROSE:** \"Negative for malignancy. Lymphocytes and anthracotic pigment. Appears reactive.\"\n\nStation 7: 12mm, appears benign, not sampled\n\n**Station 10R (right hilar):**\n- Size: 21 x 18 mm\n- Echo features: Hypoechoic, heterogeneous\n- Shape: Round\n- **Sampled:** 22G needle, 5 passes\n- **ROSE:** \"POSITIVE for malignancy. Atypical epithelial cells, favor adenocarcinoma. Recommend core biopsy for molecular testing.\"\n\nStation 11R: 10mm, not sampled (10R already positive)\n\nStations 10L, 11L: Normal size\n\n**Ion Robotic Bronchoscopy Phase:**\n\nEBUS scope out, Ion scope in through ETT.\n\nPre-procedure CT (01/31/2025", "ground_truth_entry": {"patient_mrn": "4829301", "procedure_date": "2025-02-14", "provider_role": "Attending", "attending_name": "**", "patient_age": 61, "gender": "M", "asa_class": 3, "primary_indication": "** LLL mass 5.1cm with endobronchial extension + extensive mediastinal/hilar adenopathy. Heavy smoker (80 py). Needs diagnosis and staging.", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653, 31627, 31654, 31628], "evidence": {"procedure_date": "Date: 02/14/2025", "institution_name": "City Hospital - Interventional Pulmonology Service", "attending_name": "**ATTENDING ATTESTATION:**", "patient_age": "61-year-old male, former smoker (quit 8 years ago, 45 pack-year history), presents with:", "gender": "61-year-old male, former smoker (quit 8 years ago, 45 pack-year history), presents with:", "dob": "**DOB:** 09/17/1963", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "**INDICATION:** LLL mass 5.1cm with endobronchial extension + extensive mediastinal/hilar adenopathy. Heavy smoker (80 py). Needs diagnosis and staging.", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "institution_name": "Interventional Pulmonology Service", "molecular_testing_requested": true, "disposition": "ICU Admission", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": true, "ablation_modality": "Radiofrequency (RFA)", "pleural_procedure_type": "Chest Tube", "pleural_guidance": "Ultrasound", "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["- IP clinic f/u 1 week for final path + molecular results", "- F/u 1 week IP clinic", "4. **Follow-up:**", "**PLAN & FOLLOW-UP:**", "**5. Patient Follow-Up:**", "- Follow-up appointments scheduled and confirmed"], "nav_platform": "Ion robotic bronchoscopy", "nav_registration_method": "Automatic", "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Cone Beam CT", "nav_tool_in_lesion": null, "nav_sampling_tools": ["forceps", "needle", "brush", "cryoprobe"], "nav_cryobiopsy_for_nodule": true}}
{"example_index": 32, "patient_identifier_trigger": "4829301", "field_name": "disposition", "gold_value": "icu admission", "predicted_value": "", "note_text": "**Procedure Documentation**\nMemorial Regional Medical Center\n\nDate: 02/14/2025\nPatient: Chen, Michelle Y., 71F, MRN 4829301\nProviders: Attending - Dr. James Mitchell | Fellow - Dr. Rebecca Torres\nAnesthesia: Dr. Andrew Kim (CRNA supervision)\n\n**Reason for procedure:**\n- RLL nodule 2.9cm, irregular margins, SUV 8.1\n- Right hilar lymphadenopathy (station 10R, 2.2cm, SUV 6.3)\n- Left paratracheal node (station 4L, 1.7cm, SUV 3.2)\n\nClinical question: Primary lung cancer with mediastinal spread vs other?\n\n**Procedures done:**\n1. EBUS with TBNA (mediastinal + hilar staging)\n2. Ion robotic bronchoscopy (RLL mass biopsy)\n3. Radial EBUS\n4. Cryobiopsy of RLL mass\n\n**Consent:**\nStandard risks reviewed (bleeding, PTX, infection, need for more procedures, anesthesia risks). Patient understood and consented.\n\n**Anesthesia:**\nGeneral with ETT (7.5, depth 21cm). Propofol/Sevo/Fentanyl. Pressure control ventilation: Pinsp 16, RR 14, PEEP 5, FiO2 45%.\n\n**Time-out:** Done. Patient ID confirmed, procedure confirmed, imaging reviewed.\n\n**PROCEDURE DETAILS:**\n\n**EBUS Phase:**\n\nUsed Olympus EBUS scope. Systematic node survey:\n\nStation 2R: Not enlarged\nStation 2L: Not enlarged\nStation 4R: 9mm, normal appearance\n\n**Station 4L:**\n- Size: 16 x 13 mm\n- Echo features: Hypoechoic, homogeneous\n- Shape: Oval\n- Borders: Discrete\n- Central hilar vessels: Present\n- **Sampled:** 22G needle, 4 passes\n- **ROSE:** \"Negative for malignancy. Lymphocytes and anthracotic pigment. Appears reactive.\"\n\nStation 7: 12mm, appears benign, not sampled\n\n**Station 10R (right hilar):**\n- Size: 21 x 18 mm\n- Echo features: Hypoechoic, heterogeneous\n- Shape: Round\n- **Sampled:** 22G needle, 5 passes\n- **ROSE:** \"POSITIVE for malignancy. Atypical epithelial cells, favor adenocarcinoma. Recommend core biopsy for molecular testing.\"\n\nStation 11R: 10mm, not sampled (10R already positive)\n\nStations 10L, 11L: Normal size\n\n**Ion Robotic Bronchoscopy Phase:**\n\nEBUS scope out, Ion scope in through ETT.\n\nPre-procedure CT (01/31/2025", "ground_truth_entry": {"patient_mrn": "4829301", "procedure_date": "2025-02-14", "provider_role": "Attending", "attending_name": "**", "patient_age": 61, "gender": "M", "asa_class": 3, "primary_indication": "** LLL mass 5.1cm with endobronchial extension + extensive mediastinal/hilar adenopathy. Heavy smoker (80 py). Needs diagnosis and staging.", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653, 31627, 31654, 31628], "evidence": {"procedure_date": "Date: 02/14/2025", "institution_name": "City Hospital - Interventional Pulmonology Service", "attending_name": "**ATTENDING ATTESTATION:**", "patient_age": "61-year-old male, former smoker (quit 8 years ago, 45 pack-year history), presents with:", "gender": "61-year-old male, former smoker (quit 8 years ago, 45 pack-year history), presents with:", "dob": "**DOB:** 09/17/1963", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "**INDICATION:** LLL mass 5.1cm with endobronchial extension + extensive mediastinal/hilar adenopathy. Heavy smoker (80 py). Needs diagnosis and staging.", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "institution_name": "Interventional Pulmonology Service", "molecular_testing_requested": true, "disposition": "ICU Admission", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": true, "ablation_modality": "Radiofrequency (RFA)", "pleural_procedure_type": "Chest Tube", "pleural_guidance": "Ultrasound", "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["- IP clinic f/u 1 week for final path + molecular results", "- F/u 1 week IP clinic", "4. **Follow-up:**", "**PLAN & FOLLOW-UP:**", "**5. Patient Follow-Up:**", "- Follow-up appointments scheduled and confirmed"], "nav_platform": "Ion robotic bronchoscopy", "nav_registration_method": "Automatic", "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Cone Beam CT", "nav_tool_in_lesion": null, "nav_sampling_tools": ["forceps", "needle", "brush", "cryoprobe"], "nav_cryobiopsy_for_nodule": true}}
{"example_index": 44, "patient_identifier_trigger": "6283947", "field_name": "asa_class", "gold_value": "3", "predicted_value": "", "note_text": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025", "ground_truth_entry": {"patient_mrn": "6283947", "procedure_date": "2025-02-19", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 65, "gender": "Other", "asa_class": 3, "primary_indication": "Not specified", "sedation_type": "Moderate", "airway_type": "Native", "final_diagnosis_prelim": "Other", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "sedation_type": "default Moderate (no explicit documentation)", "airway_type": "default Native (no airway device mentioned)"}, "molecular_testing_requested": false, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": [], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 44, "patient_identifier_trigger": "6283947", "field_name": "sedation_type", "gold_value": "moderate", "predicted_value": "deep", "note_text": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025", "ground_truth_entry": {"patient_mrn": "6283947", "procedure_date": "2025-02-19", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 65, "gender": "Other", "asa_class": 3, "primary_indication": "Not specified", "sedation_type": "Moderate", "airway_type": "Native", "final_diagnosis_prelim": "Other", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "sedation_type": "default Moderate (no explicit documentation)", "airway_type": "default Native (no airway device mentioned)"}, "molecular_testing_requested": false, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": [], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 44, "patient_identifier_trigger": "6283947", "field_name": "final_diagnosis_prelim", "gold_value": "other", "predicted_value": "", "note_text": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025", "ground_truth_entry": {"patient_mrn": "6283947", "procedure_date": "2025-02-19", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 65, "gender": "Other", "asa_class": 3, "primary_indication": "Not specified", "sedation_type": "Moderate", "airway_type": "Native", "final_diagnosis_prelim": "Other", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "sedation_type": "default Moderate (no explicit documentation)", "airway_type": "default Native (no airway device mentioned)"}, "molecular_testing_requested": false, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": [], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 44, "patient_identifier_trigger": "6283947", "field_name": "disposition", "gold_value": "discharge home", "predicted_value": "", "note_text": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025", "ground_truth_entry": {"patient_mrn": "6283947", "procedure_date": "2025-02-19", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 65, "gender": "Other", "asa_class": 3, "primary_indication": "Not specified", "sedation_type": "Moderate", "airway_type": "Native", "final_diagnosis_prelim": "Other", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "sedation_type": "default Moderate (no explicit documentation)", "airway_type": "default Native (no airway device mentioned)"}, "molecular_testing_requested": false, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": [], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 45, "patient_identifier_trigger": "6283947", "field_name": "procedure_date", "gold_value": "2025-02-19", "predicted_value": "", "note_text": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025\nAttending: Dr. Harris, Stephanie\nProcedure: EBUS-TBNA for suspicious nodes\nIndication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes\nConsent: Yes, documented\nMeds: Midazolam 3mg, Fentanyl 100mcg, Propofol drip (total 320mg)\nSurvey results:\n\u2022\t2R: 8mm (normal)\n\u2022\t2L: not seen\n\u2022\t4R: 21mm (sampled) - ROSE: Malignant, squamous cell features\n\u2022\t4L: 27mm (sampled) - ROSE: Squamous cell carcinoma\n\u2022\t7: 33mm (sampled) - ROSE: Squamous cell CA confirmed\n\u2022\t10L: 15mm (sampled) - ROSE: Positive for malignancy\n\u2022\t11L: 18mm (sampled) - ROSE: Reactive\nTotal passes: 14 Stations sampled: 5\nComplications: None Blood loss: Minimal\nDiagnosis: N3 disease (bilateral nodes positive) - Stage IIIB at minimum\nNext: Oncology, radiation oncology consult, tumor board\nS. Harris MD | 2/19/2025 1445\n________________________________________\n\nMETROPOLITAN HOSPITAL DEPARTMENT OF PULMONARY MEDICINE PROCEDURE DOCUMENTATION\n\u2502PATIENT\u2502 Scott, Jennifer R \u2502 MRN \u2502 4857392 \u2502 DOB \u2502 02/28/1971\n\u2502 DATE \u2502 03/30/2025\n\u2502PROCEDURE\u2502 EBUS-TBNA \u2502PROVIDER \u2502 Yang, Peter MD, PhD \u2502FELLOW \u2502 Morrison, Ashley MD\n\u2550\u2550\u2550 CLINICAL SCENARIO \u2550\u2550\u2550\n54F never-smoker with cryptogenic organizing pneumonia (COP) on CT, hilar/mediastinal lymphadenopathy. R/O sarcoid vs ILD vs atypical infection vs occult malignancy.\nPET shows moderate FDG uptake nodes at 4R, 7, 10R (SUV 3-4 range)\nLabs: Normal CBC, CMP. ACE level elevated at 82 (normal <40)\n\u2550\u2550\u2550 INFORMED CONSENT \u2550\u2550\u2550 Risks discussed: bleeding, infection, pneumothorax, failure to diagnose, need additional procedures. Patient agreed, signed consent form.\n\u2550\u2550\u2550 ANESTHESIA PROTOCOL \u2550\u2550\u2550 Moderate conscious sedation\n\u2022\tMidazolam 2mg IV at T=0\n\u2022\tFentanyl 50mcg IV at T=2min\n\u2022\tPropofol 20mg IV boluses PRN (total 80mg)\nTopical:\n\u2022\tHurricane spray (benzocaine 20%) to posterior pharynx\n\u2022\tLidocaine 2% via bronchoscope: 16mL instilled incrementally\nVitals stable throughout, SpO2 92-96% on 4L NC\n\u2550\u2550\u2550 EQUIPMENT \u2550\u2550\u2550 Pentax EB-1970UK Linear EBUS Bronchos", "ground_truth_entry": {"patient_mrn": "6283947", "procedure_date": "2025-02-19", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 68, "gender": "M", "asa_class": 3, "primary_indication": "68M smoker, LUL mass with enlarged mediastinum lymph nodes Consent: Yes, documented Meds: Midazolam 3mg, Fentanyl 100mcg, Propofol drip (total 320mg) Survey results: \u2022\t2R: 8mm (normal) \u2022\t2L: not seen \u2022\t4R: 21mm (sampled) - ROSE: Malignant, squamous cell features \u2022\t4L: 27mm (sampled) - ROSE: Squamous", "sedation_type": "General", "airway_type": "Tracheostomy", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025", "patient_age": "Indication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes", "gender": "Indication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes", "dob": "\u2502PATIENT\u2502 Scott, Jennifer R \u2502 MRN \u2502 4857392 \u2502 DOB \u2502 02/28/1971", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "Indication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes Consent: Yes, documented Meds: Midazolam 3mg, Fentanyl 100mcg, Propofol drip (total 320mg) Survey results: \u2022\t2R: 8mm (normal) \u2022\t2L: not seen \u2022\t4R: 21mm (sampled) - ROSE: Malignant, squamous cell features \u2022\t4L: 27mm (sampled) - ROSE: Squamous cell carcinoma \u2022\t7: 33mm (sampled) - ROSE: Squamous cell CA confirmed \u2022\t10L: 15mm (sampled) - ROSE: Positive for malignancy \u2022\t11L: 18mm (sampled) - ROSE: Reactive Total passes: 14 Stations sampled: 5 Complications: None Blood loss: Minimal Diagnosis: N3 disease (bilateral nodes positive) - Stage IIIB at minimum Next: Oncology, radiation oncology consult, tumor board S. Harris MD | 2/19/2025 1445 ________________________________________", "sedation_type": "propofol + paralytic (treated as GA)", "airway_type": "tracheostomy mentioned"}, "molecular_testing_requested": true, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": true, "pneumothorax_intervention": "Aspiration", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["\u25b6 FOLLOW-UP:"], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": "Fluoroscopy", "nav_tool_in_lesion": null, "nav_sampling_tools": ["needle"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 45, "patient_identifier_trigger": "6283947", "field_name": "asa_class", "gold_value": "3", "predicted_value": "", "note_text": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025\nAttending: Dr. Harris, Stephanie\nProcedure: EBUS-TBNA for suspicious nodes\nIndication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes\nConsent: Yes, documented\nMeds: Midazolam 3mg, Fentanyl 100mcg, Propofol drip (total 320mg)\nSurvey results:\n\u2022\t2R: 8mm (normal)\n\u2022\t2L: not seen\n\u2022\t4R: 21mm (sampled) - ROSE: Malignant, squamous cell features\n\u2022\t4L: 27mm (sampled) - ROSE: Squamous cell carcinoma\n\u2022\t7: 33mm (sampled) - ROSE: Squamous cell CA confirmed\n\u2022\t10L: 15mm (sampled) - ROSE: Positive for malignancy\n\u2022\t11L: 18mm (sampled) - ROSE: Reactive\nTotal passes: 14 Stations sampled: 5\nComplications: None Blood loss: Minimal\nDiagnosis: N3 disease (bilateral nodes positive) - Stage IIIB at minimum\nNext: Oncology, radiation oncology consult, tumor board\nS. Harris MD | 2/19/2025 1445\n________________________________________\n\nMETROPOLITAN HOSPITAL DEPARTMENT OF PULMONARY MEDICINE PROCEDURE DOCUMENTATION\n\u2502PATIENT\u2502 Scott, Jennifer R \u2502 MRN \u2502 4857392 \u2502 DOB \u2502 02/28/1971\n\u2502 DATE \u2502 03/30/2025\n\u2502PROCEDURE\u2502 EBUS-TBNA \u2502PROVIDER \u2502 Yang, Peter MD, PhD \u2502FELLOW \u2502 Morrison, Ashley MD\n\u2550\u2550\u2550 CLINICAL SCENARIO \u2550\u2550\u2550\n54F never-smoker with cryptogenic organizing pneumonia (COP) on CT, hilar/mediastinal lymphadenopathy. R/O sarcoid vs ILD vs atypical infection vs occult malignancy.\nPET shows moderate FDG uptake nodes at 4R, 7, 10R (SUV 3-4 range)\nLabs: Normal CBC, CMP. ACE level elevated at 82 (normal <40)\n\u2550\u2550\u2550 INFORMED CONSENT \u2550\u2550\u2550 Risks discussed: bleeding, infection, pneumothorax, failure to diagnose, need additional procedures. Patient agreed, signed consent form.\n\u2550\u2550\u2550 ANESTHESIA PROTOCOL \u2550\u2550\u2550 Moderate conscious sedation\n\u2022\tMidazolam 2mg IV at T=0\n\u2022\tFentanyl 50mcg IV at T=2min\n\u2022\tPropofol 20mg IV boluses PRN (total 80mg)\nTopical:\n\u2022\tHurricane spray (benzocaine 20%) to posterior pharynx\n\u2022\tLidocaine 2% via bronchoscope: 16mL instilled incrementally\nVitals stable throughout, SpO2 92-96% on 4L NC\n\u2550\u2550\u2550 EQUIPMENT \u2550\u2550\u2550 Pentax EB-1970UK Linear EBUS Bronchos", "ground_truth_entry": {"patient_mrn": "6283947", "procedure_date": "2025-02-19", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 68, "gender": "M", "asa_class": 3, "primary_indication": "68M smoker, LUL mass with enlarged mediastinum lymph nodes Consent: Yes, documented Meds: Midazolam 3mg, Fentanyl 100mcg, Propofol drip (total 320mg) Survey results: \u2022\t2R: 8mm (normal) \u2022\t2L: not seen \u2022\t4R: 21mm (sampled) - ROSE: Malignant, squamous cell features \u2022\t4L: 27mm (sampled) - ROSE: Squamous", "sedation_type": "General", "airway_type": "Tracheostomy", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025", "patient_age": "Indication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes", "gender": "Indication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes", "dob": "\u2502PATIENT\u2502 Scott, Jennifer R \u2502 MRN \u2502 4857392 \u2502 DOB \u2502 02/28/1971", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "Indication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes Consent: Yes, documented Meds: Midazolam 3mg, Fentanyl 100mcg, Propofol drip (total 320mg) Survey results: \u2022\t2R: 8mm (normal) \u2022\t2L: not seen \u2022\t4R: 21mm (sampled) - ROSE: Malignant, squamous cell features \u2022\t4L: 27mm (sampled) - ROSE: Squamous cell carcinoma \u2022\t7: 33mm (sampled) - ROSE: Squamous cell CA confirmed \u2022\t10L: 15mm (sampled) - ROSE: Positive for malignancy \u2022\t11L: 18mm (sampled) - ROSE: Reactive Total passes: 14 Stations sampled: 5 Complications: None Blood loss: Minimal Diagnosis: N3 disease (bilateral nodes positive) - Stage IIIB at minimum Next: Oncology, radiation oncology consult, tumor board S. Harris MD | 2/19/2025 1445 ________________________________________", "sedation_type": "propofol + paralytic (treated as GA)", "airway_type": "tracheostomy mentioned"}, "molecular_testing_requested": true, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": true, "pneumothorax_intervention": "Aspiration", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["\u25b6 FOLLOW-UP:"], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": "Fluoroscopy", "nav_tool_in_lesion": null, "nav_sampling_tools": ["needle"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 45, "patient_identifier_trigger": "6283947", "field_name": "sedation_type", "gold_value": "general", "predicted_value": "", "note_text": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025\nAttending: Dr. Harris, Stephanie\nProcedure: EBUS-TBNA for suspicious nodes\nIndication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes\nConsent: Yes, documented\nMeds: Midazolam 3mg, Fentanyl 100mcg, Propofol drip (total 320mg)\nSurvey results:\n\u2022\t2R: 8mm (normal)\n\u2022\t2L: not seen\n\u2022\t4R: 21mm (sampled) - ROSE: Malignant, squamous cell features\n\u2022\t4L: 27mm (sampled) - ROSE: Squamous cell carcinoma\n\u2022\t7: 33mm (sampled) - ROSE: Squamous cell CA confirmed\n\u2022\t10L: 15mm (sampled) - ROSE: Positive for malignancy\n\u2022\t11L: 18mm (sampled) - ROSE: Reactive\nTotal passes: 14 Stations sampled: 5\nComplications: None Blood loss: Minimal\nDiagnosis: N3 disease (bilateral nodes positive) - Stage IIIB at minimum\nNext: Oncology, radiation oncology consult, tumor board\nS. Harris MD | 2/19/2025 1445\n________________________________________\n\nMETROPOLITAN HOSPITAL DEPARTMENT OF PULMONARY MEDICINE PROCEDURE DOCUMENTATION\n\u2502PATIENT\u2502 Scott, Jennifer R \u2502 MRN \u2502 4857392 \u2502 DOB \u2502 02/28/1971\n\u2502 DATE \u2502 03/30/2025\n\u2502PROCEDURE\u2502 EBUS-TBNA \u2502PROVIDER \u2502 Yang, Peter MD, PhD \u2502FELLOW \u2502 Morrison, Ashley MD\n\u2550\u2550\u2550 CLINICAL SCENARIO \u2550\u2550\u2550\n54F never-smoker with cryptogenic organizing pneumonia (COP) on CT, hilar/mediastinal lymphadenopathy. R/O sarcoid vs ILD vs atypical infection vs occult malignancy.\nPET shows moderate FDG uptake nodes at 4R, 7, 10R (SUV 3-4 range)\nLabs: Normal CBC, CMP. ACE level elevated at 82 (normal <40)\n\u2550\u2550\u2550 INFORMED CONSENT \u2550\u2550\u2550 Risks discussed: bleeding, infection, pneumothorax, failure to diagnose, need additional procedures. Patient agreed, signed consent form.\n\u2550\u2550\u2550 ANESTHESIA PROTOCOL \u2550\u2550\u2550 Moderate conscious sedation\n\u2022\tMidazolam 2mg IV at T=0\n\u2022\tFentanyl 50mcg IV at T=2min\n\u2022\tPropofol 20mg IV boluses PRN (total 80mg)\nTopical:\n\u2022\tHurricane spray (benzocaine 20%) to posterior pharynx\n\u2022\tLidocaine 2% via bronchoscope: 16mL instilled incrementally\nVitals stable throughout, SpO2 92-96% on 4L NC\n\u2550\u2550\u2550 EQUIPMENT \u2550\u2550\u2550 Pentax EB-1970UK Linear EBUS Bronchos", "ground_truth_entry": {"patient_mrn": "6283947", "procedure_date": "2025-02-19", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 68, "gender": "M", "asa_class": 3, "primary_indication": "68M smoker, LUL mass with enlarged mediastinum lymph nodes Consent: Yes, documented Meds: Midazolam 3mg, Fentanyl 100mcg, Propofol drip (total 320mg) Survey results: \u2022\t2R: 8mm (normal) \u2022\t2L: not seen \u2022\t4R: 21mm (sampled) - ROSE: Malignant, squamous cell features \u2022\t4L: 27mm (sampled) - ROSE: Squamous", "sedation_type": "General", "airway_type": "Tracheostomy", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025", "patient_age": "Indication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes", "gender": "Indication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes", "dob": "\u2502PATIENT\u2502 Scott, Jennifer R \u2502 MRN \u2502 4857392 \u2502 DOB \u2502 02/28/1971", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "Indication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes Consent: Yes, documented Meds: Midazolam 3mg, Fentanyl 100mcg, Propofol drip (total 320mg) Survey results: \u2022\t2R: 8mm (normal) \u2022\t2L: not seen \u2022\t4R: 21mm (sampled) - ROSE: Malignant, squamous cell features \u2022\t4L: 27mm (sampled) - ROSE: Squamous cell carcinoma \u2022\t7: 33mm (sampled) - ROSE: Squamous cell CA confirmed \u2022\t10L: 15mm (sampled) - ROSE: Positive for malignancy \u2022\t11L: 18mm (sampled) - ROSE: Reactive Total passes: 14 Stations sampled: 5 Complications: None Blood loss: Minimal Diagnosis: N3 disease (bilateral nodes positive) - Stage IIIB at minimum Next: Oncology, radiation oncology consult, tumor board S. Harris MD | 2/19/2025 1445 ________________________________________", "sedation_type": "propofol + paralytic (treated as GA)", "airway_type": "tracheostomy mentioned"}, "molecular_testing_requested": true, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": true, "pneumothorax_intervention": "Aspiration", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["\u25b6 FOLLOW-UP:"], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": "Fluoroscopy", "nav_tool_in_lesion": null, "nav_sampling_tools": ["needle"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 45, "patient_identifier_trigger": "6283947", "field_name": "airway_type", "gold_value": "tracheostomy", "predicted_value": "", "note_text": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025\nAttending: Dr. Harris, Stephanie\nProcedure: EBUS-TBNA for suspicious nodes\nIndication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes\nConsent: Yes, documented\nMeds: Midazolam 3mg, Fentanyl 100mcg, Propofol drip (total 320mg)\nSurvey results:\n\u2022\t2R: 8mm (normal)\n\u2022\t2L: not seen\n\u2022\t4R: 21mm (sampled) - ROSE: Malignant, squamous cell features\n\u2022\t4L: 27mm (sampled) - ROSE: Squamous cell carcinoma\n\u2022\t7: 33mm (sampled) - ROSE: Squamous cell CA confirmed\n\u2022\t10L: 15mm (sampled) - ROSE: Positive for malignancy\n\u2022\t11L: 18mm (sampled) - ROSE: Reactive\nTotal passes: 14 Stations sampled: 5\nComplications: None Blood loss: Minimal\nDiagnosis: N3 disease (bilateral nodes positive) - Stage IIIB at minimum\nNext: Oncology, radiation oncology consult, tumor board\nS. Harris MD | 2/19/2025 1445\n________________________________________\n\nMETROPOLITAN HOSPITAL DEPARTMENT OF PULMONARY MEDICINE PROCEDURE DOCUMENTATION\n\u2502PATIENT\u2502 Scott, Jennifer R \u2502 MRN \u2502 4857392 \u2502 DOB \u2502 02/28/1971\n\u2502 DATE \u2502 03/30/2025\n\u2502PROCEDURE\u2502 EBUS-TBNA \u2502PROVIDER \u2502 Yang, Peter MD, PhD \u2502FELLOW \u2502 Morrison, Ashley MD\n\u2550\u2550\u2550 CLINICAL SCENARIO \u2550\u2550\u2550\n54F never-smoker with cryptogenic organizing pneumonia (COP) on CT, hilar/mediastinal lymphadenopathy. R/O sarcoid vs ILD vs atypical infection vs occult malignancy.\nPET shows moderate FDG uptake nodes at 4R, 7, 10R (SUV 3-4 range)\nLabs: Normal CBC, CMP. ACE level elevated at 82 (normal <40)\n\u2550\u2550\u2550 INFORMED CONSENT \u2550\u2550\u2550 Risks discussed: bleeding, infection, pneumothorax, failure to diagnose, need additional procedures. Patient agreed, signed consent form.\n\u2550\u2550\u2550 ANESTHESIA PROTOCOL \u2550\u2550\u2550 Moderate conscious sedation\n\u2022\tMidazolam 2mg IV at T=0\n\u2022\tFentanyl 50mcg IV at T=2min\n\u2022\tPropofol 20mg IV boluses PRN (total 80mg)\nTopical:\n\u2022\tHurricane spray (benzocaine 20%) to posterior pharynx\n\u2022\tLidocaine 2% via bronchoscope: 16mL instilled incrementally\nVitals stable throughout, SpO2 92-96% on 4L NC\n\u2550\u2550\u2550 EQUIPMENT \u2550\u2550\u2550 Pentax EB-1970UK Linear EBUS Bronchos", "ground_truth_entry": {"patient_mrn": "6283947", "procedure_date": "2025-02-19", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 68, "gender": "M", "asa_class": 3, "primary_indication": "68M smoker, LUL mass with enlarged mediastinum lymph nodes Consent: Yes, documented Meds: Midazolam 3mg, Fentanyl 100mcg, Propofol drip (total 320mg) Survey results: \u2022\t2R: 8mm (normal) \u2022\t2L: not seen \u2022\t4R: 21mm (sampled) - ROSE: Malignant, squamous cell features \u2022\t4L: 27mm (sampled) - ROSE: Squamous", "sedation_type": "General", "airway_type": "Tracheostomy", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025", "patient_age": "Indication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes", "gender": "Indication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes", "dob": "\u2502PATIENT\u2502 Scott, Jennifer R \u2502 MRN \u2502 4857392 \u2502 DOB \u2502 02/28/1971", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "Indication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes Consent: Yes, documented Meds: Midazolam 3mg, Fentanyl 100mcg, Propofol drip (total 320mg) Survey results: \u2022\t2R: 8mm (normal) \u2022\t2L: not seen \u2022\t4R: 21mm (sampled) - ROSE: Malignant, squamous cell features \u2022\t4L: 27mm (sampled) - ROSE: Squamous cell carcinoma \u2022\t7: 33mm (sampled) - ROSE: Squamous cell CA confirmed \u2022\t10L: 15mm (sampled) - ROSE: Positive for malignancy \u2022\t11L: 18mm (sampled) - ROSE: Reactive Total passes: 14 Stations sampled: 5 Complications: None Blood loss: Minimal Diagnosis: N3 disease (bilateral nodes positive) - Stage IIIB at minimum Next: Oncology, radiation oncology consult, tumor board S. Harris MD | 2/19/2025 1445 ________________________________________", "sedation_type": "propofol + paralytic (treated as GA)", "airway_type": "tracheostomy mentioned"}, "molecular_testing_requested": true, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": true, "pneumothorax_intervention": "Aspiration", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["\u25b6 FOLLOW-UP:"], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": "Fluoroscopy", "nav_tool_in_lesion": null, "nav_sampling_tools": ["needle"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 45, "patient_identifier_trigger": "6283947", "field_name": "final_diagnosis_prelim", "gold_value": "malignancy", "predicted_value": "", "note_text": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025\nAttending: Dr. Harris, Stephanie\nProcedure: EBUS-TBNA for suspicious nodes\nIndication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes\nConsent: Yes, documented\nMeds: Midazolam 3mg, Fentanyl 100mcg, Propofol drip (total 320mg)\nSurvey results:\n\u2022\t2R: 8mm (normal)\n\u2022\t2L: not seen\n\u2022\t4R: 21mm (sampled) - ROSE: Malignant, squamous cell features\n\u2022\t4L: 27mm (sampled) - ROSE: Squamous cell carcinoma\n\u2022\t7: 33mm (sampled) - ROSE: Squamous cell CA confirmed\n\u2022\t10L: 15mm (sampled) - ROSE: Positive for malignancy\n\u2022\t11L: 18mm (sampled) - ROSE: Reactive\nTotal passes: 14 Stations sampled: 5\nComplications: None Blood loss: Minimal\nDiagnosis: N3 disease (bilateral nodes positive) - Stage IIIB at minimum\nNext: Oncology, radiation oncology consult, tumor board\nS. Harris MD | 2/19/2025 1445\n________________________________________\n\nMETROPOLITAN HOSPITAL DEPARTMENT OF PULMONARY MEDICINE PROCEDURE DOCUMENTATION\n\u2502PATIENT\u2502 Scott, Jennifer R \u2502 MRN \u2502 4857392 \u2502 DOB \u2502 02/28/1971\n\u2502 DATE \u2502 03/30/2025\n\u2502PROCEDURE\u2502 EBUS-TBNA \u2502PROVIDER \u2502 Yang, Peter MD, PhD \u2502FELLOW \u2502 Morrison, Ashley MD\n\u2550\u2550\u2550 CLINICAL SCENARIO \u2550\u2550\u2550\n54F never-smoker with cryptogenic organizing pneumonia (COP) on CT, hilar/mediastinal lymphadenopathy. R/O sarcoid vs ILD vs atypical infection vs occult malignancy.\nPET shows moderate FDG uptake nodes at 4R, 7, 10R (SUV 3-4 range)\nLabs: Normal CBC, CMP. ACE level elevated at 82 (normal <40)\n\u2550\u2550\u2550 INFORMED CONSENT \u2550\u2550\u2550 Risks discussed: bleeding, infection, pneumothorax, failure to diagnose, need additional procedures. Patient agreed, signed consent form.\n\u2550\u2550\u2550 ANESTHESIA PROTOCOL \u2550\u2550\u2550 Moderate conscious sedation\n\u2022\tMidazolam 2mg IV at T=0\n\u2022\tFentanyl 50mcg IV at T=2min\n\u2022\tPropofol 20mg IV boluses PRN (total 80mg)\nTopical:\n\u2022\tHurricane spray (benzocaine 20%) to posterior pharynx\n\u2022\tLidocaine 2% via bronchoscope: 16mL instilled incrementally\nVitals stable throughout, SpO2 92-96% on 4L NC\n\u2550\u2550\u2550 EQUIPMENT \u2550\u2550\u2550 Pentax EB-1970UK Linear EBUS Bronchos", "ground_truth_entry": {"patient_mrn": "6283947", "procedure_date": "2025-02-19", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 68, "gender": "M", "asa_class": 3, "primary_indication": "68M smoker, LUL mass with enlarged mediastinum lymph nodes Consent: Yes, documented Meds: Midazolam 3mg, Fentanyl 100mcg, Propofol drip (total 320mg) Survey results: \u2022\t2R: 8mm (normal) \u2022\t2L: not seen \u2022\t4R: 21mm (sampled) - ROSE: Malignant, squamous cell features \u2022\t4L: 27mm (sampled) - ROSE: Squamous", "sedation_type": "General", "airway_type": "Tracheostomy", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025", "patient_age": "Indication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes", "gender": "Indication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes", "dob": "\u2502PATIENT\u2502 Scott, Jennifer R \u2502 MRN \u2502 4857392 \u2502 DOB \u2502 02/28/1971", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "Indication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes Consent: Yes, documented Meds: Midazolam 3mg, Fentanyl 100mcg, Propofol drip (total 320mg) Survey results: \u2022\t2R: 8mm (normal) \u2022\t2L: not seen \u2022\t4R: 21mm (sampled) - ROSE: Malignant, squamous cell features \u2022\t4L: 27mm (sampled) - ROSE: Squamous cell carcinoma \u2022\t7: 33mm (sampled) - ROSE: Squamous cell CA confirmed \u2022\t10L: 15mm (sampled) - ROSE: Positive for malignancy \u2022\t11L: 18mm (sampled) - ROSE: Reactive Total passes: 14 Stations sampled: 5 Complications: None Blood loss: Minimal Diagnosis: N3 disease (bilateral nodes positive) - Stage IIIB at minimum Next: Oncology, radiation oncology consult, tumor board S. Harris MD | 2/19/2025 1445 ________________________________________", "sedation_type": "propofol + paralytic (treated as GA)", "airway_type": "tracheostomy mentioned"}, "molecular_testing_requested": true, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": true, "pneumothorax_intervention": "Aspiration", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["\u25b6 FOLLOW-UP:"], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": "Fluoroscopy", "nav_tool_in_lesion": null, "nav_sampling_tools": ["needle"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 45, "patient_identifier_trigger": "6283947", "field_name": "disposition", "gold_value": "discharge home", "predicted_value": "", "note_text": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025\nAttending: Dr. Harris, Stephanie\nProcedure: EBUS-TBNA for suspicious nodes\nIndication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes\nConsent: Yes, documented\nMeds: Midazolam 3mg, Fentanyl 100mcg, Propofol drip (total 320mg)\nSurvey results:\n\u2022\t2R: 8mm (normal)\n\u2022\t2L: not seen\n\u2022\t4R: 21mm (sampled) - ROSE: Malignant, squamous cell features\n\u2022\t4L: 27mm (sampled) - ROSE: Squamous cell carcinoma\n\u2022\t7: 33mm (sampled) - ROSE: Squamous cell CA confirmed\n\u2022\t10L: 15mm (sampled) - ROSE: Positive for malignancy\n\u2022\t11L: 18mm (sampled) - ROSE: Reactive\nTotal passes: 14 Stations sampled: 5\nComplications: None Blood loss: Minimal\nDiagnosis: N3 disease (bilateral nodes positive) - Stage IIIB at minimum\nNext: Oncology, radiation oncology consult, tumor board\nS. Harris MD | 2/19/2025 1445\n________________________________________\n\nMETROPOLITAN HOSPITAL DEPARTMENT OF PULMONARY MEDICINE PROCEDURE DOCUMENTATION\n\u2502PATIENT\u2502 Scott, Jennifer R \u2502 MRN \u2502 4857392 \u2502 DOB \u2502 02/28/1971\n\u2502 DATE \u2502 03/30/2025\n\u2502PROCEDURE\u2502 EBUS-TBNA \u2502PROVIDER \u2502 Yang, Peter MD, PhD \u2502FELLOW \u2502 Morrison, Ashley MD\n\u2550\u2550\u2550 CLINICAL SCENARIO \u2550\u2550\u2550\n54F never-smoker with cryptogenic organizing pneumonia (COP) on CT, hilar/mediastinal lymphadenopathy. R/O sarcoid vs ILD vs atypical infection vs occult malignancy.\nPET shows moderate FDG uptake nodes at 4R, 7, 10R (SUV 3-4 range)\nLabs: Normal CBC, CMP. ACE level elevated at 82 (normal <40)\n\u2550\u2550\u2550 INFORMED CONSENT \u2550\u2550\u2550 Risks discussed: bleeding, infection, pneumothorax, failure to diagnose, need additional procedures. Patient agreed, signed consent form.\n\u2550\u2550\u2550 ANESTHESIA PROTOCOL \u2550\u2550\u2550 Moderate conscious sedation\n\u2022\tMidazolam 2mg IV at T=0\n\u2022\tFentanyl 50mcg IV at T=2min\n\u2022\tPropofol 20mg IV boluses PRN (total 80mg)\nTopical:\n\u2022\tHurricane spray (benzocaine 20%) to posterior pharynx\n\u2022\tLidocaine 2% via bronchoscope: 16mL instilled incrementally\nVitals stable throughout, SpO2 92-96% on 4L NC\n\u2550\u2550\u2550 EQUIPMENT \u2550\u2550\u2550 Pentax EB-1970UK Linear EBUS Bronchos", "ground_truth_entry": {"patient_mrn": "6283947", "procedure_date": "2025-02-19", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 68, "gender": "M", "asa_class": 3, "primary_indication": "68M smoker, LUL mass with enlarged mediastinum lymph nodes Consent: Yes, documented Meds: Midazolam 3mg, Fentanyl 100mcg, Propofol drip (total 320mg) Survey results: \u2022\t2R: 8mm (normal) \u2022\t2L: not seen \u2022\t4R: 21mm (sampled) - ROSE: Malignant, squamous cell features \u2022\t4L: 27mm (sampled) - ROSE: Squamous", "sedation_type": "General", "airway_type": "Tracheostomy", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Cooper, Daniel | ID#: 6283947 | Date: 02/19/2025", "patient_age": "Indication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes", "gender": "Indication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes", "dob": "\u2502PATIENT\u2502 Scott, Jennifer R \u2502 MRN \u2502 4857392 \u2502 DOB \u2502 02/28/1971", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "Indication: 68M smoker, LUL mass with enlarged mediastinum lymph nodes Consent: Yes, documented Meds: Midazolam 3mg, Fentanyl 100mcg, Propofol drip (total 320mg) Survey results: \u2022\t2R: 8mm (normal) \u2022\t2L: not seen \u2022\t4R: 21mm (sampled) - ROSE: Malignant, squamous cell features \u2022\t4L: 27mm (sampled) - ROSE: Squamous cell carcinoma \u2022\t7: 33mm (sampled) - ROSE: Squamous cell CA confirmed \u2022\t10L: 15mm (sampled) - ROSE: Positive for malignancy \u2022\t11L: 18mm (sampled) - ROSE: Reactive Total passes: 14 Stations sampled: 5 Complications: None Blood loss: Minimal Diagnosis: N3 disease (bilateral nodes positive) - Stage IIIB at minimum Next: Oncology, radiation oncology consult, tumor board S. Harris MD | 2/19/2025 1445 ________________________________________", "sedation_type": "propofol + paralytic (treated as GA)", "airway_type": "tracheostomy mentioned"}, "molecular_testing_requested": true, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": true, "pneumothorax_intervention": "Aspiration", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["\u25b6 FOLLOW-UP:"], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": "Fluoroscopy", "nav_tool_in_lesion": null, "nav_sampling_tools": ["needle"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 96, "patient_identifier_trigger": "56789012", "field_name": "procedure_date", "gold_value": "2025-01-01", "predicted_value": "", "note_text": "BLVR PROCEDURE 10/29/2024\n\nPatient: Thomas O'Brien | DOB: 06/15/1954 | MRN: 56789012\nInstitution: Duke University Hospital, Durham, NC  \nPhysician: Rachel Goldstein, MD\n\nS: 70M severe LUL emphysema\nO: Chartis (-) CV in LUL  \nA: Candidate for EBV placement\nP: Proceed with valve placement\n\nProcedure:\n- FB under mod sedation\n- LUL visualization  \n- 4 Zephyr valves placed (LB1+2, LB3, lingula)\n- Complete occlusion confirmed\n\nDisposition: Admit, stable\n\nRachel Goldstein, MD\nDuke IP Service", "ground_truth_entry": {"patient_mrn": "56789012", "procedure_date": "2025-01-01", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 70, "gender": "M", "asa_class": 3, "primary_indication": "Not specified", "sedation_type": "Moderate", "airway_type": "Native", "final_diagnosis_prelim": "Other", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31647], "evidence": {"institution_name": "Institution: Duke University Hospital, Durham, NC", "patient_age": "S: 70M severe LUL emphysema", "gender": "S: 70M severe LUL emphysema", "dob": "Patient: Thomas O'Brien | DOB: 06/15/1954 | MRN: 56789012", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "sedation_type": "default Moderate (no explicit documentation)", "airway_type": "default Native (no airway device mentioned)"}, "institution_name": "Duke University Hospital, Durham, NC", "molecular_testing_requested": false, "disposition": "Floor Admission", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": "LUL", "blvr_valve_type": "Zephyr", "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": [], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 96, "patient_identifier_trigger": "56789012", "field_name": "asa_class", "gold_value": "3", "predicted_value": "", "note_text": "BLVR PROCEDURE 10/29/2024\n\nPatient: Thomas O'Brien | DOB: 06/15/1954 | MRN: 56789012\nInstitution: Duke University Hospital, Durham, NC  \nPhysician: Rachel Goldstein, MD\n\nS: 70M severe LUL emphysema\nO: Chartis (-) CV in LUL  \nA: Candidate for EBV placement\nP: Proceed with valve placement\n\nProcedure:\n- FB under mod sedation\n- LUL visualization  \n- 4 Zephyr valves placed (LB1+2, LB3, lingula)\n- Complete occlusion confirmed\n\nDisposition: Admit, stable\n\nRachel Goldstein, MD\nDuke IP Service", "ground_truth_entry": {"patient_mrn": "56789012", "procedure_date": "2025-01-01", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 70, "gender": "M", "asa_class": 3, "primary_indication": "Not specified", "sedation_type": "Moderate", "airway_type": "Native", "final_diagnosis_prelim": "Other", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31647], "evidence": {"institution_name": "Institution: Duke University Hospital, Durham, NC", "patient_age": "S: 70M severe LUL emphysema", "gender": "S: 70M severe LUL emphysema", "dob": "Patient: Thomas O'Brien | DOB: 06/15/1954 | MRN: 56789012", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "sedation_type": "default Moderate (no explicit documentation)", "airway_type": "default Native (no airway device mentioned)"}, "institution_name": "Duke University Hospital, Durham, NC", "molecular_testing_requested": false, "disposition": "Floor Admission", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": "LUL", "blvr_valve_type": "Zephyr", "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": [], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 96, "patient_identifier_trigger": "56789012", "field_name": "final_diagnosis_prelim", "gold_value": "other", "predicted_value": "", "note_text": "BLVR PROCEDURE 10/29/2024\n\nPatient: Thomas O'Brien | DOB: 06/15/1954 | MRN: 56789012\nInstitution: Duke University Hospital, Durham, NC  \nPhysician: Rachel Goldstein, MD\n\nS: 70M severe LUL emphysema\nO: Chartis (-) CV in LUL  \nA: Candidate for EBV placement\nP: Proceed with valve placement\n\nProcedure:\n- FB under mod sedation\n- LUL visualization  \n- 4 Zephyr valves placed (LB1+2, LB3, lingula)\n- Complete occlusion confirmed\n\nDisposition: Admit, stable\n\nRachel Goldstein, MD\nDuke IP Service", "ground_truth_entry": {"patient_mrn": "56789012", "procedure_date": "2025-01-01", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 70, "gender": "M", "asa_class": 3, "primary_indication": "Not specified", "sedation_type": "Moderate", "airway_type": "Native", "final_diagnosis_prelim": "Other", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31647], "evidence": {"institution_name": "Institution: Duke University Hospital, Durham, NC", "patient_age": "S: 70M severe LUL emphysema", "gender": "S: 70M severe LUL emphysema", "dob": "Patient: Thomas O'Brien | DOB: 06/15/1954 | MRN: 56789012", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "sedation_type": "default Moderate (no explicit documentation)", "airway_type": "default Native (no airway device mentioned)"}, "institution_name": "Duke University Hospital, Durham, NC", "molecular_testing_requested": false, "disposition": "Floor Admission", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": "LUL", "blvr_valve_type": "Zephyr", "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": [], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 115, "patient_identifier_trigger": "A47829C", "field_name": "procedure_date", "gold_value": "2025-01-01", "predicted_value": "", "note_text": "MRN A47829C | DOB 08/14/1959 | Pt: David Kim\n\nINDICATION: LUL peripheral ground-glass nodule 9mm, no bronchus sign, slow growth over 18mo\n\nMEDS: Local anesthesia only - topical lidocaine 4% nebulized + transtracheal 2% lidocaine\nPatient awake, cooperative throughout (Ramsay 2)\n\nTECHNIQUE:\n- Virtual bronchoscopy planning completed pre-procedure\n- Electromagnetic navigation system utilized\n- Target registration successful, error <5mm\n- Extended working channel advanced to LUL apical-posterior segment\n- Radial EBUS probe confirmed tool-in-lesion - eccentric pattern initially, adjusted to concentric\n- Fluoroscopy used for confirmation: 2.8 minutes total time, DAP 98 cGy*cm\u00b2\n\nSAMPLING:\nTransbronchial needle aspiration \u00d72\nTransbronchial forceps biopsy \u00d74 (small samples given GGO nature)\nCytology brush \u00d71\n\nSAFETY: No pneumothorax on immediate post-procedure CXR. No bleeding. SpO2 stable 96-98% throughout.\n\nSUCCESS METRICS: Tool-in-lesion confirmed, localization successful, diagnostic sampling completed per protocol.", "ground_truth_entry": {"patient_mrn": "A47829C", "procedure_date": "2025-01-01", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 65, "gender": "Other", "asa_class": 3, "primary_indication": "LUL peripheral ground-glass nodule 9mm, no bronchus sign, slow growth over 18mo", "sedation_type": "Moderate", "airway_type": "Tracheostomy", "final_diagnosis_prelim": "Other", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31627, 31654, 31629, 31628], "evidence": {"dob": "MRN A47829C | DOB 08/14/1959 | Pt: David Kim", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "INDICATION: LUL peripheral ground-glass nodule 9mm, no bronchus sign, slow growth over 18mo", "sedation_type": "local anesthesia only (mapped to Moderate)", "airway_type": "tracheostomy mentioned"}, "molecular_testing_requested": false, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": "EMN", "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Fluoroscopy", "nav_tool_in_lesion": true, "nav_sampling_tools": ["forceps", "needle", "brush"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 115, "patient_identifier_trigger": "A47829C", "field_name": "asa_class", "gold_value": "3", "predicted_value": "", "note_text": "MRN A47829C | DOB 08/14/1959 | Pt: David Kim\n\nINDICATION: LUL peripheral ground-glass nodule 9mm, no bronchus sign, slow growth over 18mo\n\nMEDS: Local anesthesia only - topical lidocaine 4% nebulized + transtracheal 2% lidocaine\nPatient awake, cooperative throughout (Ramsay 2)\n\nTECHNIQUE:\n- Virtual bronchoscopy planning completed pre-procedure\n- Electromagnetic navigation system utilized\n- Target registration successful, error <5mm\n- Extended working channel advanced to LUL apical-posterior segment\n- Radial EBUS probe confirmed tool-in-lesion - eccentric pattern initially, adjusted to concentric\n- Fluoroscopy used for confirmation: 2.8 minutes total time, DAP 98 cGy*cm\u00b2\n\nSAMPLING:\nTransbronchial needle aspiration \u00d72\nTransbronchial forceps biopsy \u00d74 (small samples given GGO nature)\nCytology brush \u00d71\n\nSAFETY: No pneumothorax on immediate post-procedure CXR. No bleeding. SpO2 stable 96-98% throughout.\n\nSUCCESS METRICS: Tool-in-lesion confirmed, localization successful, diagnostic sampling completed per protocol.", "ground_truth_entry": {"patient_mrn": "A47829C", "procedure_date": "2025-01-01", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 65, "gender": "Other", "asa_class": 3, "primary_indication": "LUL peripheral ground-glass nodule 9mm, no bronchus sign, slow growth over 18mo", "sedation_type": "Moderate", "airway_type": "Tracheostomy", "final_diagnosis_prelim": "Other", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31627, 31654, 31629, 31628], "evidence": {"dob": "MRN A47829C | DOB 08/14/1959 | Pt: David Kim", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "INDICATION: LUL peripheral ground-glass nodule 9mm, no bronchus sign, slow growth over 18mo", "sedation_type": "local anesthesia only (mapped to Moderate)", "airway_type": "tracheostomy mentioned"}, "molecular_testing_requested": false, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": "EMN", "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Fluoroscopy", "nav_tool_in_lesion": true, "nav_sampling_tools": ["forceps", "needle", "brush"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 115, "patient_identifier_trigger": "A47829C", "field_name": "sedation_type", "gold_value": "moderate", "predicted_value": "local", "note_text": "MRN A47829C | DOB 08/14/1959 | Pt: David Kim\n\nINDICATION: LUL peripheral ground-glass nodule 9mm, no bronchus sign, slow growth over 18mo\n\nMEDS: Local anesthesia only - topical lidocaine 4% nebulized + transtracheal 2% lidocaine\nPatient awake, cooperative throughout (Ramsay 2)\n\nTECHNIQUE:\n- Virtual bronchoscopy planning completed pre-procedure\n- Electromagnetic navigation system utilized\n- Target registration successful, error <5mm\n- Extended working channel advanced to LUL apical-posterior segment\n- Radial EBUS probe confirmed tool-in-lesion - eccentric pattern initially, adjusted to concentric\n- Fluoroscopy used for confirmation: 2.8 minutes total time, DAP 98 cGy*cm\u00b2\n\nSAMPLING:\nTransbronchial needle aspiration \u00d72\nTransbronchial forceps biopsy \u00d74 (small samples given GGO nature)\nCytology brush \u00d71\n\nSAFETY: No pneumothorax on immediate post-procedure CXR. No bleeding. SpO2 stable 96-98% throughout.\n\nSUCCESS METRICS: Tool-in-lesion confirmed, localization successful, diagnostic sampling completed per protocol.", "ground_truth_entry": {"patient_mrn": "A47829C", "procedure_date": "2025-01-01", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 65, "gender": "Other", "asa_class": 3, "primary_indication": "LUL peripheral ground-glass nodule 9mm, no bronchus sign, slow growth over 18mo", "sedation_type": "Moderate", "airway_type": "Tracheostomy", "final_diagnosis_prelim": "Other", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31627, 31654, 31629, 31628], "evidence": {"dob": "MRN A47829C | DOB 08/14/1959 | Pt: David Kim", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "INDICATION: LUL peripheral ground-glass nodule 9mm, no bronchus sign, slow growth over 18mo", "sedation_type": "local anesthesia only (mapped to Moderate)", "airway_type": "tracheostomy mentioned"}, "molecular_testing_requested": false, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": "EMN", "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Fluoroscopy", "nav_tool_in_lesion": true, "nav_sampling_tools": ["forceps", "needle", "brush"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 115, "patient_identifier_trigger": "A47829C", "field_name": "airway_type", "gold_value": "tracheostomy", "predicted_value": "native", "note_text": "MRN A47829C | DOB 08/14/1959 | Pt: David Kim\n\nINDICATION: LUL peripheral ground-glass nodule 9mm, no bronchus sign, slow growth over 18mo\n\nMEDS: Local anesthesia only - topical lidocaine 4% nebulized + transtracheal 2% lidocaine\nPatient awake, cooperative throughout (Ramsay 2)\n\nTECHNIQUE:\n- Virtual bronchoscopy planning completed pre-procedure\n- Electromagnetic navigation system utilized\n- Target registration successful, error <5mm\n- Extended working channel advanced to LUL apical-posterior segment\n- Radial EBUS probe confirmed tool-in-lesion - eccentric pattern initially, adjusted to concentric\n- Fluoroscopy used for confirmation: 2.8 minutes total time, DAP 98 cGy*cm\u00b2\n\nSAMPLING:\nTransbronchial needle aspiration \u00d72\nTransbronchial forceps biopsy \u00d74 (small samples given GGO nature)\nCytology brush \u00d71\n\nSAFETY: No pneumothorax on immediate post-procedure CXR. No bleeding. SpO2 stable 96-98% throughout.\n\nSUCCESS METRICS: Tool-in-lesion confirmed, localization successful, diagnostic sampling completed per protocol.", "ground_truth_entry": {"patient_mrn": "A47829C", "procedure_date": "2025-01-01", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 65, "gender": "Other", "asa_class": 3, "primary_indication": "LUL peripheral ground-glass nodule 9mm, no bronchus sign, slow growth over 18mo", "sedation_type": "Moderate", "airway_type": "Tracheostomy", "final_diagnosis_prelim": "Other", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31627, 31654, 31629, 31628], "evidence": {"dob": "MRN A47829C | DOB 08/14/1959 | Pt: David Kim", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "INDICATION: LUL peripheral ground-glass nodule 9mm, no bronchus sign, slow growth over 18mo", "sedation_type": "local anesthesia only (mapped to Moderate)", "airway_type": "tracheostomy mentioned"}, "molecular_testing_requested": false, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": "EMN", "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Fluoroscopy", "nav_tool_in_lesion": true, "nav_sampling_tools": ["forceps", "needle", "brush"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 115, "patient_identifier_trigger": "A47829C", "field_name": "final_diagnosis_prelim", "gold_value": "other", "predicted_value": "", "note_text": "MRN A47829C | DOB 08/14/1959 | Pt: David Kim\n\nINDICATION: LUL peripheral ground-glass nodule 9mm, no bronchus sign, slow growth over 18mo\n\nMEDS: Local anesthesia only - topical lidocaine 4% nebulized + transtracheal 2% lidocaine\nPatient awake, cooperative throughout (Ramsay 2)\n\nTECHNIQUE:\n- Virtual bronchoscopy planning completed pre-procedure\n- Electromagnetic navigation system utilized\n- Target registration successful, error <5mm\n- Extended working channel advanced to LUL apical-posterior segment\n- Radial EBUS probe confirmed tool-in-lesion - eccentric pattern initially, adjusted to concentric\n- Fluoroscopy used for confirmation: 2.8 minutes total time, DAP 98 cGy*cm\u00b2\n\nSAMPLING:\nTransbronchial needle aspiration \u00d72\nTransbronchial forceps biopsy \u00d74 (small samples given GGO nature)\nCytology brush \u00d71\n\nSAFETY: No pneumothorax on immediate post-procedure CXR. No bleeding. SpO2 stable 96-98% throughout.\n\nSUCCESS METRICS: Tool-in-lesion confirmed, localization successful, diagnostic sampling completed per protocol.", "ground_truth_entry": {"patient_mrn": "A47829C", "procedure_date": "2025-01-01", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 65, "gender": "Other", "asa_class": 3, "primary_indication": "LUL peripheral ground-glass nodule 9mm, no bronchus sign, slow growth over 18mo", "sedation_type": "Moderate", "airway_type": "Tracheostomy", "final_diagnosis_prelim": "Other", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31627, 31654, 31629, 31628], "evidence": {"dob": "MRN A47829C | DOB 08/14/1959 | Pt: David Kim", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "INDICATION: LUL peripheral ground-glass nodule 9mm, no bronchus sign, slow growth over 18mo", "sedation_type": "local anesthesia only (mapped to Moderate)", "airway_type": "tracheostomy mentioned"}, "molecular_testing_requested": false, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": "EMN", "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Fluoroscopy", "nav_tool_in_lesion": true, "nav_sampling_tools": ["forceps", "needle", "brush"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 115, "patient_identifier_trigger": "A47829C", "field_name": "disposition", "gold_value": "discharge home", "predicted_value": "", "note_text": "MRN A47829C | DOB 08/14/1959 | Pt: David Kim\n\nINDICATION: LUL peripheral ground-glass nodule 9mm, no bronchus sign, slow growth over 18mo\n\nMEDS: Local anesthesia only - topical lidocaine 4% nebulized + transtracheal 2% lidocaine\nPatient awake, cooperative throughout (Ramsay 2)\n\nTECHNIQUE:\n- Virtual bronchoscopy planning completed pre-procedure\n- Electromagnetic navigation system utilized\n- Target registration successful, error <5mm\n- Extended working channel advanced to LUL apical-posterior segment\n- Radial EBUS probe confirmed tool-in-lesion - eccentric pattern initially, adjusted to concentric\n- Fluoroscopy used for confirmation: 2.8 minutes total time, DAP 98 cGy*cm\u00b2\n\nSAMPLING:\nTransbronchial needle aspiration \u00d72\nTransbronchial forceps biopsy \u00d74 (small samples given GGO nature)\nCytology brush \u00d71\n\nSAFETY: No pneumothorax on immediate post-procedure CXR. No bleeding. SpO2 stable 96-98% throughout.\n\nSUCCESS METRICS: Tool-in-lesion confirmed, localization successful, diagnostic sampling completed per protocol.", "ground_truth_entry": {"patient_mrn": "A47829C", "procedure_date": "2025-01-01", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 65, "gender": "Other", "asa_class": 3, "primary_indication": "LUL peripheral ground-glass nodule 9mm, no bronchus sign, slow growth over 18mo", "sedation_type": "Moderate", "airway_type": "Tracheostomy", "final_diagnosis_prelim": "Other", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31627, 31654, 31629, 31628], "evidence": {"dob": "MRN A47829C | DOB 08/14/1959 | Pt: David Kim", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "INDICATION: LUL peripheral ground-glass nodule 9mm, no bronchus sign, slow growth over 18mo", "sedation_type": "local anesthesia only (mapped to Moderate)", "airway_type": "tracheostomy mentioned"}, "molecular_testing_requested": false, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": "EMN", "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": true, "nav_rebus_view": "Concentric", "nav_imaging_verification": "Fluoroscopy", "nav_tool_in_lesion": true, "nav_sampling_tools": ["forceps", "needle", "brush"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 126, "patient_identifier_trigger": "JJ-8374-Q", "field_name": "procedure_date", "gold_value": "2025-01-01", "predicted_value": "", "note_text": "This seventy-three year old female patient Catherine Martinez (medical record JJ-8374-Q, born September 8, 1951) presented for electromagnetic navigation bronchoscopy targeting a left upper lobe peripheral nodule measuring twenty-three millimeters in greatest dimension on computed tomography. The lesion demonstrated a positive bronchus sign and had a standardized uptake value of five point two on positron emission tomography imaging suggesting malignancy. She underwent moderate conscious sedation with intravenous midazolam three milligrams and fentanyl one hundred micrograms achieving a Ramsay sedation score of three. Her blood pressure was monitored at ten minute intervals throughout and remained stable in the one twenties to one thirties over seventies to eighties. Oxygen saturation was continuously monitored and stayed above ninety-five percent on room air. The electromagnetic navigation system was utilized with successful registration to the preoperative CT scan. The guide sheath was advanced to the left upper lobe apical-posterior segment and the radial endobronchial ultrasound probe confirmed tool-in-lesion position with a concentric echogenic pattern consistent with solid tissue. Total fluoroscopy time was five point one minutes with a dose area product of one hundred ninety-two centigray centimeters squared. Sampling included three needle aspirations using a twenty-one gauge needle, four transbronchial forceps biopsies, and two brush cytology specimens. There was minimal bleeding after the forceps biopsies which resolved spontaneously with gentle suction. Post-procedure chest radiograph showed no pneumothorax or significant change from baseline. The patient tolerated the procedure well and was discharged home after two hours of observation in stable condition.", "ground_truth_entry": {"patient_mrn": "JJ-8374-Q", "procedure_date": "2025-01-01", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 65, "gender": "F", "asa_class": 3, "primary_indication": "Not specified", "sedation_type": "Moderate", "airway_type": "Native", "final_diagnosis_prelim": "Other", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31627, 31654, 31629, 31628], "evidence": {"gender": "This seventy-three year old female patient Catherine Martinez (medical record JJ-8374-Q, born September 8, 1951) presented for electromagnetic navigation bronchoscopy targeting a left upper lobe peripheral nodule measuring twenty-three millimeters in greatest dimension on computed tomography. The lesion demonstrated a positive bronchus sign and had a standardized uptake value of five point two on positron emission tomography imaging suggesting malignancy. She underwent moderate conscious sedation with intravenous midazolam three milligrams and fentanyl one hundred micrograms achieving a Ramsay sedation score of three. Her blood pressure was monitored at ten minute intervals throughout and remained stable in the one twenties to one thirties over seventies to eighties. Oxygen saturation was continuously monitored and stayed above ninety-five percent on room air. The electromagnetic navigation system was utilized with successful registration to the preoperative CT scan. The guide sheath was advanced to the left upper lobe apical-posterior segment and the radial endobronchial ultrasound probe confirmed tool-in-lesion position with a concentric echogenic pattern consistent with solid tissue. Total fluoroscopy time was five point one minutes with a dose area product of one hundred ninety-two centigray centimeters squared. Sampling included three needle aspirations using a twenty-one gauge needle, four transbronchial forceps biopsies, and two brush cytology specimens. There was minimal bleeding after the forceps biopsies which resolved spontaneously with gentle suction. Post-procedure chest radiograph showed no pneumothorax or significant change from baseline. The patient tolerated the procedure well and was discharged home after two hours of observation in stable condition.", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "sedation_type": "opioid/benzo sedation (treated as Moderate)", "airway_type": "native airway / spontaneous breathing"}, "molecular_testing_requested": false, "disposition": "Discharge Home", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": "EMN", "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": "Fluoroscopy", "nav_tool_in_lesion": true, "nav_sampling_tools": ["forceps", "needle", "brush"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 126, "patient_identifier_trigger": "JJ-8374-Q", "field_name": "asa_class", "gold_value": "3", "predicted_value": "", "note_text": "This seventy-three year old female patient Catherine Martinez (medical record JJ-8374-Q, born September 8, 1951) presented for electromagnetic navigation bronchoscopy targeting a left upper lobe peripheral nodule measuring twenty-three millimeters in greatest dimension on computed tomography. The lesion demonstrated a positive bronchus sign and had a standardized uptake value of five point two on positron emission tomography imaging suggesting malignancy. She underwent moderate conscious sedation with intravenous midazolam three milligrams and fentanyl one hundred micrograms achieving a Ramsay sedation score of three. Her blood pressure was monitored at ten minute intervals throughout and remained stable in the one twenties to one thirties over seventies to eighties. Oxygen saturation was continuously monitored and stayed above ninety-five percent on room air. The electromagnetic navigation system was utilized with successful registration to the preoperative CT scan. The guide sheath was advanced to the left upper lobe apical-posterior segment and the radial endobronchial ultrasound probe confirmed tool-in-lesion position with a concentric echogenic pattern consistent with solid tissue. Total fluoroscopy time was five point one minutes with a dose area product of one hundred ninety-two centigray centimeters squared. Sampling included three needle aspirations using a twenty-one gauge needle, four transbronchial forceps biopsies, and two brush cytology specimens. There was minimal bleeding after the forceps biopsies which resolved spontaneously with gentle suction. Post-procedure chest radiograph showed no pneumothorax or significant change from baseline. The patient tolerated the procedure well and was discharged home after two hours of observation in stable condition.", "ground_truth_entry": {"patient_mrn": "JJ-8374-Q", "procedure_date": "2025-01-01", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 65, "gender": "F", "asa_class": 3, "primary_indication": "Not specified", "sedation_type": "Moderate", "airway_type": "Native", "final_diagnosis_prelim": "Other", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31627, 31654, 31629, 31628], "evidence": {"gender": "This seventy-three year old female patient Catherine Martinez (medical record JJ-8374-Q, born September 8, 1951) presented for electromagnetic navigation bronchoscopy targeting a left upper lobe peripheral nodule measuring twenty-three millimeters in greatest dimension on computed tomography. The lesion demonstrated a positive bronchus sign and had a standardized uptake value of five point two on positron emission tomography imaging suggesting malignancy. She underwent moderate conscious sedation with intravenous midazolam three milligrams and fentanyl one hundred micrograms achieving a Ramsay sedation score of three. Her blood pressure was monitored at ten minute intervals throughout and remained stable in the one twenties to one thirties over seventies to eighties. Oxygen saturation was continuously monitored and stayed above ninety-five percent on room air. The electromagnetic navigation system was utilized with successful registration to the preoperative CT scan. The guide sheath was advanced to the left upper lobe apical-posterior segment and the radial endobronchial ultrasound probe confirmed tool-in-lesion position with a concentric echogenic pattern consistent with solid tissue. Total fluoroscopy time was five point one minutes with a dose area product of one hundred ninety-two centigray centimeters squared. Sampling included three needle aspirations using a twenty-one gauge needle, four transbronchial forceps biopsies, and two brush cytology specimens. There was minimal bleeding after the forceps biopsies which resolved spontaneously with gentle suction. Post-procedure chest radiograph showed no pneumothorax or significant change from baseline. The patient tolerated the procedure well and was discharged home after two hours of observation in stable condition.", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "sedation_type": "opioid/benzo sedation (treated as Moderate)", "airway_type": "native airway / spontaneous breathing"}, "molecular_testing_requested": false, "disposition": "Discharge Home", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": "EMN", "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": "Fluoroscopy", "nav_tool_in_lesion": true, "nav_sampling_tools": ["forceps", "needle", "brush"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 126, "patient_identifier_trigger": "JJ-8374-Q", "field_name": "final_diagnosis_prelim", "gold_value": "other", "predicted_value": "malignancy", "note_text": "This seventy-three year old female patient Catherine Martinez (medical record JJ-8374-Q, born September 8, 1951) presented for electromagnetic navigation bronchoscopy targeting a left upper lobe peripheral nodule measuring twenty-three millimeters in greatest dimension on computed tomography. The lesion demonstrated a positive bronchus sign and had a standardized uptake value of five point two on positron emission tomography imaging suggesting malignancy. She underwent moderate conscious sedation with intravenous midazolam three milligrams and fentanyl one hundred micrograms achieving a Ramsay sedation score of three. Her blood pressure was monitored at ten minute intervals throughout and remained stable in the one twenties to one thirties over seventies to eighties. Oxygen saturation was continuously monitored and stayed above ninety-five percent on room air. The electromagnetic navigation system was utilized with successful registration to the preoperative CT scan. The guide sheath was advanced to the left upper lobe apical-posterior segment and the radial endobronchial ultrasound probe confirmed tool-in-lesion position with a concentric echogenic pattern consistent with solid tissue. Total fluoroscopy time was five point one minutes with a dose area product of one hundred ninety-two centigray centimeters squared. Sampling included three needle aspirations using a twenty-one gauge needle, four transbronchial forceps biopsies, and two brush cytology specimens. There was minimal bleeding after the forceps biopsies which resolved spontaneously with gentle suction. Post-procedure chest radiograph showed no pneumothorax or significant change from baseline. The patient tolerated the procedure well and was discharged home after two hours of observation in stable condition.", "ground_truth_entry": {"patient_mrn": "JJ-8374-Q", "procedure_date": "2025-01-01", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 65, "gender": "F", "asa_class": 3, "primary_indication": "Not specified", "sedation_type": "Moderate", "airway_type": "Native", "final_diagnosis_prelim": "Other", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31627, 31654, 31629, 31628], "evidence": {"gender": "This seventy-three year old female patient Catherine Martinez (medical record JJ-8374-Q, born September 8, 1951) presented for electromagnetic navigation bronchoscopy targeting a left upper lobe peripheral nodule measuring twenty-three millimeters in greatest dimension on computed tomography. The lesion demonstrated a positive bronchus sign and had a standardized uptake value of five point two on positron emission tomography imaging suggesting malignancy. She underwent moderate conscious sedation with intravenous midazolam three milligrams and fentanyl one hundred micrograms achieving a Ramsay sedation score of three. Her blood pressure was monitored at ten minute intervals throughout and remained stable in the one twenties to one thirties over seventies to eighties. Oxygen saturation was continuously monitored and stayed above ninety-five percent on room air. The electromagnetic navigation system was utilized with successful registration to the preoperative CT scan. The guide sheath was advanced to the left upper lobe apical-posterior segment and the radial endobronchial ultrasound probe confirmed tool-in-lesion position with a concentric echogenic pattern consistent with solid tissue. Total fluoroscopy time was five point one minutes with a dose area product of one hundred ninety-two centigray centimeters squared. Sampling included three needle aspirations using a twenty-one gauge needle, four transbronchial forceps biopsies, and two brush cytology specimens. There was minimal bleeding after the forceps biopsies which resolved spontaneously with gentle suction. Post-procedure chest radiograph showed no pneumothorax or significant change from baseline. The patient tolerated the procedure well and was discharged home after two hours of observation in stable condition.", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "sedation_type": "opioid/benzo sedation (treated as Moderate)", "airway_type": "native airway / spontaneous breathing"}, "molecular_testing_requested": false, "disposition": "Discharge Home", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": "EMN", "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": "Fluoroscopy", "nav_tool_in_lesion": true, "nav_sampling_tools": ["forceps", "needle", "brush"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 126, "patient_identifier_trigger": "JJ-8374-Q", "field_name": "ebus_needle_gauge", "gold_value": "", "predicted_value": "21g", "note_text": "This seventy-three year old female patient Catherine Martinez (medical record JJ-8374-Q, born September 8, 1951) presented for electromagnetic navigation bronchoscopy targeting a left upper lobe peripheral nodule measuring twenty-three millimeters in greatest dimension on computed tomography. The lesion demonstrated a positive bronchus sign and had a standardized uptake value of five point two on positron emission tomography imaging suggesting malignancy. She underwent moderate conscious sedation with intravenous midazolam three milligrams and fentanyl one hundred micrograms achieving a Ramsay sedation score of three. Her blood pressure was monitored at ten minute intervals throughout and remained stable in the one twenties to one thirties over seventies to eighties. Oxygen saturation was continuously monitored and stayed above ninety-five percent on room air. The electromagnetic navigation system was utilized with successful registration to the preoperative CT scan. The guide sheath was advanced to the left upper lobe apical-posterior segment and the radial endobronchial ultrasound probe confirmed tool-in-lesion position with a concentric echogenic pattern consistent with solid tissue. Total fluoroscopy time was five point one minutes with a dose area product of one hundred ninety-two centigray centimeters squared. Sampling included three needle aspirations using a twenty-one gauge needle, four transbronchial forceps biopsies, and two brush cytology specimens. There was minimal bleeding after the forceps biopsies which resolved spontaneously with gentle suction. Post-procedure chest radiograph showed no pneumothorax or significant change from baseline. The patient tolerated the procedure well and was discharged home after two hours of observation in stable condition.", "ground_truth_entry": {"patient_mrn": "JJ-8374-Q", "procedure_date": "2025-01-01", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 65, "gender": "F", "asa_class": 3, "primary_indication": "Not specified", "sedation_type": "Moderate", "airway_type": "Native", "final_diagnosis_prelim": "Other", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31627, 31654, 31629, 31628], "evidence": {"gender": "This seventy-three year old female patient Catherine Martinez (medical record JJ-8374-Q, born September 8, 1951) presented for electromagnetic navigation bronchoscopy targeting a left upper lobe peripheral nodule measuring twenty-three millimeters in greatest dimension on computed tomography. The lesion demonstrated a positive bronchus sign and had a standardized uptake value of five point two on positron emission tomography imaging suggesting malignancy. She underwent moderate conscious sedation with intravenous midazolam three milligrams and fentanyl one hundred micrograms achieving a Ramsay sedation score of three. Her blood pressure was monitored at ten minute intervals throughout and remained stable in the one twenties to one thirties over seventies to eighties. Oxygen saturation was continuously monitored and stayed above ninety-five percent on room air. The electromagnetic navigation system was utilized with successful registration to the preoperative CT scan. The guide sheath was advanced to the left upper lobe apical-posterior segment and the radial endobronchial ultrasound probe confirmed tool-in-lesion position with a concentric echogenic pattern consistent with solid tissue. Total fluoroscopy time was five point one minutes with a dose area product of one hundred ninety-two centigray centimeters squared. Sampling included three needle aspirations using a twenty-one gauge needle, four transbronchial forceps biopsies, and two brush cytology specimens. There was minimal bleeding after the forceps biopsies which resolved spontaneously with gentle suction. Post-procedure chest radiograph showed no pneumothorax or significant change from baseline. The patient tolerated the procedure well and was discharged home after two hours of observation in stable condition.", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "sedation_type": "opioid/benzo sedation (treated as Moderate)", "airway_type": "native airway / spontaneous breathing"}, "molecular_testing_requested": false, "disposition": "Discharge Home", "bleeding_severity": "Mild", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": "EMN", "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": "Fluoroscopy", "nav_tool_in_lesion": true, "nav_sampling_tools": ["forceps", "needle", "brush"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 129, "patient_identifier_trigger": "KK-9473-L", "field_name": "procedure_date", "gold_value": "2025-01-01", "predicted_value": "2024-10-15", "note_text": "PROTOCOL: Bronchoscopy Registry Study #2024-BR-0847\nSUBJECT ID: S-047\nDEMOGRAPHICS: 68 y.o. male, former smoker (40 pack-years, quit 2018)\nDATE: 2024-10-15\nOPERATOR: De-identified per protocol\n\nPRIMARY INDICATION: Mediastinal lymph node staging\nTARGET PATHOLOGY: Right lower lobe adenocarcinoma (biopsy-proven)\n\nANESTHESIA PROTOCOL:\n\u2514\u2500 Agent: Midazolam IV\n   \u251c\u2500 Dose: 2mg initial, 1mg supplemental at T+15min\n   \u2514\u2500 Total: 3mg\n\u2514\u2500 Agent: Fentanyl IV\n   \u251c\u2500 Dose: 50mcg initial, 25mcg supplemental at T+20min\n   \u2514\u2500 Total: 75mcg\n\u2514\u2500 Sedation Level: Ramsay Scale maximum 3\n\u2514\u2500 Monitoring Frequency: BP q5min, continuous SpO2\n\nEBUS-TBNA STATIONS SAMPLED:\n\u251c\u2500 Station 4R\n\u2502  \u251c\u2500 Size: 10mm short-axis\n\u2502  \u251c\u2500 Passes: 4\n\u2502  \u251c\u2500 ROSE: Positive for malignant cells\n\u2502  \u2514\u2500 PET: Positive (SUV 6.2)\n\u251c\u2500 Station 7\n\u2502  \u251c\u2500 Size: 15mm short-axis\n\u2502  \u251c\u2500 Passes: 4\n\u2502  \u251c\u2500 ROSE: Positive for malignant cells\n\u2502  \u2514\u2500 PET: Positive (SUV 8.1)\n\u2514\u2500 Station 10R\n   \u251c\u2500 Size: 7mm short-axis\n   \u251c\u2500 Passes: 3\n   \u251c\u2500 ROSE: Adequate, benign lymphocytes\n   \u2514\u2500 PET: Negative\n\nQUALITY METRICS:\n\u251c\u2500 Systematic evaluation (N3\u2192N2\u2192N1): YES\n\u251c\u2500 Photodocumentation all accessible stations: YES\n\u251c\u2500 ROSE adequacy all sampled nodes: YES\n\u251c\u2500 Molecular testing samples obtained: YES (from station 7)\n\u2514\u2500 Protocol adherence: 100%\n\nADVERSE EVENTS:\n\u2514\u2500 None (Grade 0)\n\nDIAGNOSTIC YIELD: Pending final pathology (preliminary: N2 disease confirmed)\n\nPATIENT IDENTIFIERS (SYNTHETIC):\nName: Robert Anderson | MRN: KK-9473-L | DOB: 05/19/1956", "ground_truth_entry": {"patient_mrn": "KK-9473-L", "procedure_date": "2025-01-01", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 65, "gender": "M", "asa_class": 3, "primary_indication": "Mediastinal lymph node staging TARGET PATHOLOGY: Right lower lobe adenocarcinoma (biopsy-proven)", "sedation_type": "Moderate", "airway_type": "Native", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"gender": "DEMOGRAPHICS: 68 y.o. male, former smoker (40 pack-years, quit 2018)", "dob": "Name: Robert Anderson | MRN: KK-9473-L | DOB: 05/19/1956", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "PRIMARY INDICATION: Mediastinal lymph node staging TARGET PATHOLOGY: Right lower lobe adenocarcinoma (biopsy-proven)", "sedation_type": "opioid/benzo sedation (treated as Moderate)", "airway_type": "default Native (no airway device mentioned)"}, "molecular_testing_requested": true, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": [], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 129, "patient_identifier_trigger": "KK-9473-L", "field_name": "asa_class", "gold_value": "3", "predicted_value": "", "note_text": "PROTOCOL: Bronchoscopy Registry Study #2024-BR-0847\nSUBJECT ID: S-047\nDEMOGRAPHICS: 68 y.o. male, former smoker (40 pack-years, quit 2018)\nDATE: 2024-10-15\nOPERATOR: De-identified per protocol\n\nPRIMARY INDICATION: Mediastinal lymph node staging\nTARGET PATHOLOGY: Right lower lobe adenocarcinoma (biopsy-proven)\n\nANESTHESIA PROTOCOL:\n\u2514\u2500 Agent: Midazolam IV\n   \u251c\u2500 Dose: 2mg initial, 1mg supplemental at T+15min\n   \u2514\u2500 Total: 3mg\n\u2514\u2500 Agent: Fentanyl IV\n   \u251c\u2500 Dose: 50mcg initial, 25mcg supplemental at T+20min\n   \u2514\u2500 Total: 75mcg\n\u2514\u2500 Sedation Level: Ramsay Scale maximum 3\n\u2514\u2500 Monitoring Frequency: BP q5min, continuous SpO2\n\nEBUS-TBNA STATIONS SAMPLED:\n\u251c\u2500 Station 4R\n\u2502  \u251c\u2500 Size: 10mm short-axis\n\u2502  \u251c\u2500 Passes: 4\n\u2502  \u251c\u2500 ROSE: Positive for malignant cells\n\u2502  \u2514\u2500 PET: Positive (SUV 6.2)\n\u251c\u2500 Station 7\n\u2502  \u251c\u2500 Size: 15mm short-axis\n\u2502  \u251c\u2500 Passes: 4\n\u2502  \u251c\u2500 ROSE: Positive for malignant cells\n\u2502  \u2514\u2500 PET: Positive (SUV 8.1)\n\u2514\u2500 Station 10R\n   \u251c\u2500 Size: 7mm short-axis\n   \u251c\u2500 Passes: 3\n   \u251c\u2500 ROSE: Adequate, benign lymphocytes\n   \u2514\u2500 PET: Negative\n\nQUALITY METRICS:\n\u251c\u2500 Systematic evaluation (N3\u2192N2\u2192N1): YES\n\u251c\u2500 Photodocumentation all accessible stations: YES\n\u251c\u2500 ROSE adequacy all sampled nodes: YES\n\u251c\u2500 Molecular testing samples obtained: YES (from station 7)\n\u2514\u2500 Protocol adherence: 100%\n\nADVERSE EVENTS:\n\u2514\u2500 None (Grade 0)\n\nDIAGNOSTIC YIELD: Pending final pathology (preliminary: N2 disease confirmed)\n\nPATIENT IDENTIFIERS (SYNTHETIC):\nName: Robert Anderson | MRN: KK-9473-L | DOB: 05/19/1956", "ground_truth_entry": {"patient_mrn": "KK-9473-L", "procedure_date": "2025-01-01", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 65, "gender": "M", "asa_class": 3, "primary_indication": "Mediastinal lymph node staging TARGET PATHOLOGY: Right lower lobe adenocarcinoma (biopsy-proven)", "sedation_type": "Moderate", "airway_type": "Native", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"gender": "DEMOGRAPHICS: 68 y.o. male, former smoker (40 pack-years, quit 2018)", "dob": "Name: Robert Anderson | MRN: KK-9473-L | DOB: 05/19/1956", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "PRIMARY INDICATION: Mediastinal lymph node staging TARGET PATHOLOGY: Right lower lobe adenocarcinoma (biopsy-proven)", "sedation_type": "opioid/benzo sedation (treated as Moderate)", "airway_type": "default Native (no airway device mentioned)"}, "molecular_testing_requested": true, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": [], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 129, "patient_identifier_trigger": "KK-9473-L", "field_name": "disposition", "gold_value": "discharge home", "predicted_value": "", "note_text": "PROTOCOL: Bronchoscopy Registry Study #2024-BR-0847\nSUBJECT ID: S-047\nDEMOGRAPHICS: 68 y.o. male, former smoker (40 pack-years, quit 2018)\nDATE: 2024-10-15\nOPERATOR: De-identified per protocol\n\nPRIMARY INDICATION: Mediastinal lymph node staging\nTARGET PATHOLOGY: Right lower lobe adenocarcinoma (biopsy-proven)\n\nANESTHESIA PROTOCOL:\n\u2514\u2500 Agent: Midazolam IV\n   \u251c\u2500 Dose: 2mg initial, 1mg supplemental at T+15min\n   \u2514\u2500 Total: 3mg\n\u2514\u2500 Agent: Fentanyl IV\n   \u251c\u2500 Dose: 50mcg initial, 25mcg supplemental at T+20min\n   \u2514\u2500 Total: 75mcg\n\u2514\u2500 Sedation Level: Ramsay Scale maximum 3\n\u2514\u2500 Monitoring Frequency: BP q5min, continuous SpO2\n\nEBUS-TBNA STATIONS SAMPLED:\n\u251c\u2500 Station 4R\n\u2502  \u251c\u2500 Size: 10mm short-axis\n\u2502  \u251c\u2500 Passes: 4\n\u2502  \u251c\u2500 ROSE: Positive for malignant cells\n\u2502  \u2514\u2500 PET: Positive (SUV 6.2)\n\u251c\u2500 Station 7\n\u2502  \u251c\u2500 Size: 15mm short-axis\n\u2502  \u251c\u2500 Passes: 4\n\u2502  \u251c\u2500 ROSE: Positive for malignant cells\n\u2502  \u2514\u2500 PET: Positive (SUV 8.1)\n\u2514\u2500 Station 10R\n   \u251c\u2500 Size: 7mm short-axis\n   \u251c\u2500 Passes: 3\n   \u251c\u2500 ROSE: Adequate, benign lymphocytes\n   \u2514\u2500 PET: Negative\n\nQUALITY METRICS:\n\u251c\u2500 Systematic evaluation (N3\u2192N2\u2192N1): YES\n\u251c\u2500 Photodocumentation all accessible stations: YES\n\u251c\u2500 ROSE adequacy all sampled nodes: YES\n\u251c\u2500 Molecular testing samples obtained: YES (from station 7)\n\u2514\u2500 Protocol adherence: 100%\n\nADVERSE EVENTS:\n\u2514\u2500 None (Grade 0)\n\nDIAGNOSTIC YIELD: Pending final pathology (preliminary: N2 disease confirmed)\n\nPATIENT IDENTIFIERS (SYNTHETIC):\nName: Robert Anderson | MRN: KK-9473-L | DOB: 05/19/1956", "ground_truth_entry": {"patient_mrn": "KK-9473-L", "procedure_date": "2025-01-01", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 65, "gender": "M", "asa_class": 3, "primary_indication": "Mediastinal lymph node staging TARGET PATHOLOGY: Right lower lobe adenocarcinoma (biopsy-proven)", "sedation_type": "Moderate", "airway_type": "Native", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"gender": "DEMOGRAPHICS: 68 y.o. male, former smoker (40 pack-years, quit 2018)", "dob": "Name: Robert Anderson | MRN: KK-9473-L | DOB: 05/19/1956", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "PRIMARY INDICATION: Mediastinal lymph node staging TARGET PATHOLOGY: Right lower lobe adenocarcinoma (biopsy-proven)", "sedation_type": "opioid/benzo sedation (treated as Moderate)", "airway_type": "default Native (no airway device mentioned)"}, "molecular_testing_requested": true, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": [], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 129, "patient_identifier_trigger": "KK-9473-L", "field_name": "ebus_rose_result", "gold_value": "", "predicted_value": "malignant", "note_text": "PROTOCOL: Bronchoscopy Registry Study #2024-BR-0847\nSUBJECT ID: S-047\nDEMOGRAPHICS: 68 y.o. male, former smoker (40 pack-years, quit 2018)\nDATE: 2024-10-15\nOPERATOR: De-identified per protocol\n\nPRIMARY INDICATION: Mediastinal lymph node staging\nTARGET PATHOLOGY: Right lower lobe adenocarcinoma (biopsy-proven)\n\nANESTHESIA PROTOCOL:\n\u2514\u2500 Agent: Midazolam IV\n   \u251c\u2500 Dose: 2mg initial, 1mg supplemental at T+15min\n   \u2514\u2500 Total: 3mg\n\u2514\u2500 Agent: Fentanyl IV\n   \u251c\u2500 Dose: 50mcg initial, 25mcg supplemental at T+20min\n   \u2514\u2500 Total: 75mcg\n\u2514\u2500 Sedation Level: Ramsay Scale maximum 3\n\u2514\u2500 Monitoring Frequency: BP q5min, continuous SpO2\n\nEBUS-TBNA STATIONS SAMPLED:\n\u251c\u2500 Station 4R\n\u2502  \u251c\u2500 Size: 10mm short-axis\n\u2502  \u251c\u2500 Passes: 4\n\u2502  \u251c\u2500 ROSE: Positive for malignant cells\n\u2502  \u2514\u2500 PET: Positive (SUV 6.2)\n\u251c\u2500 Station 7\n\u2502  \u251c\u2500 Size: 15mm short-axis\n\u2502  \u251c\u2500 Passes: 4\n\u2502  \u251c\u2500 ROSE: Positive for malignant cells\n\u2502  \u2514\u2500 PET: Positive (SUV 8.1)\n\u2514\u2500 Station 10R\n   \u251c\u2500 Size: 7mm short-axis\n   \u251c\u2500 Passes: 3\n   \u251c\u2500 ROSE: Adequate, benign lymphocytes\n   \u2514\u2500 PET: Negative\n\nQUALITY METRICS:\n\u251c\u2500 Systematic evaluation (N3\u2192N2\u2192N1): YES\n\u251c\u2500 Photodocumentation all accessible stations: YES\n\u251c\u2500 ROSE adequacy all sampled nodes: YES\n\u251c\u2500 Molecular testing samples obtained: YES (from station 7)\n\u2514\u2500 Protocol adherence: 100%\n\nADVERSE EVENTS:\n\u2514\u2500 None (Grade 0)\n\nDIAGNOSTIC YIELD: Pending final pathology (preliminary: N2 disease confirmed)\n\nPATIENT IDENTIFIERS (SYNTHETIC):\nName: Robert Anderson | MRN: KK-9473-L | DOB: 05/19/1956", "ground_truth_entry": {"patient_mrn": "KK-9473-L", "procedure_date": "2025-01-01", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 65, "gender": "M", "asa_class": 3, "primary_indication": "Mediastinal lymph node staging TARGET PATHOLOGY: Right lower lobe adenocarcinoma (biopsy-proven)", "sedation_type": "Moderate", "airway_type": "Native", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"gender": "DEMOGRAPHICS: 68 y.o. male, former smoker (40 pack-years, quit 2018)", "dob": "Name: Robert Anderson | MRN: KK-9473-L | DOB: 05/19/1956", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "PRIMARY INDICATION: Mediastinal lymph node staging TARGET PATHOLOGY: Right lower lobe adenocarcinoma (biopsy-proven)", "sedation_type": "opioid/benzo sedation (treated as Moderate)", "airway_type": "default Native (no airway device mentioned)"}, "molecular_testing_requested": true, "disposition": "Discharge Home", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": [], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": [], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 136, "patient_identifier_trigger": "MR4729384", "field_name": "patient_mrn", "gold_value": "mr4729384", "predicted_value": "8362719", "note_text": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)\nEndobronchial Ultrasound Bronchoscopy\nIndication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging\nPre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology\nAnesthesia: General anesthesia provided by anesthesia team (Dr. Martinez)\nEquipment: Pentax EB-1970UK linear EBUS scope\nProcedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination:\nLymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic\n\u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance\nTBNA sampling:\nStation 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified\nStation 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed\nStation 4L (24mm) 3 passes performed\nROSE: Malignant cells present\nStation 10R (18mm) 2 passes performed ROSE: Atypical cells\nProcedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition\nPreliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing\nPatient counseled post-procedure regarding findings\nNext steps: Oncology consult, PET-CT for full staging\nSigned: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15\n________________________________________\nEBUS\nBRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedu", "ground_truth_entry": {"patient_mrn": "MR4729384", "procedure_date": "2025-03-05", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 72, "gender": "Other", "asa_class": 3, "primary_indication": "Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Proc", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "patient_age": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "dob": "BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "Indication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Procedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination: Lymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic \u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance TBNA sampling: Station 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified Station 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed Station 4L (24mm) 3 passes performed ROSE: Malignant cells present Station 10R (18mm) 2 passes performed ROSE: Atypical cells Procedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition Preliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing Patient counseled post-procedure regarding findings Next steps: Oncology consult, PET-CT for full staging Signed: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15 ________________________________________ EBUS BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025 Provider: Elliott, Mark DO | Interventional Pulmonology INDICATION: Mediastinal lymphadenopathy, suspected lymphoma based on PET findings INFORMED CONSENT: Obtained, documented in chart PROCEDURE: EBUS-TBNA with ROSE ANESTHESIA: Conscious sedation - Fentanyl 100mcg IV, Midazolam 4mg IV Local - Lidocaine 4% spray, Lidocaine 2% 20cc via working channel EQUIPMENT: Olympus EBUS bronchoscope TECHNIQUE: EBUS scope introduced through mouth after adequate sedation. Vocal cords normal. Mediastinal ultrasound survey performed with following findings: Station 2R: Not enlarged Station 4R: 29mm, ABNORMAL - round, hypoechoic, loss of hilum Station 4L: 26mm, ABNORMAL - similar features Station 7: 47mm, MARKEDLY ABNORMAL - huge subcarinal node, diffuse hypoechoic pattern Station 10R: 14mm, mildly enlarged Station 10L: 19mm, enlarged Station 11R: 22mm, ABNORMAL appearance Station 11L: 20mm, ABNORMAL appearance SAMPLING DETAILS: Station 7 (47x29mm) - SUBCARINAL Pass 1: 22G needle, excellent tissue yield ROSE: Abundant large atypical lymphoid cells, HIGH SUSPICION for lymphoma Pass 2: Additional specimen for flow cytometry Pass 3: Additional specimen for flow cytometry Pass 4: Cell block preparation Station 4R (29x17mm) Pass 1-3: Consistent with Station 7 ROSE: Large atypical lymphoid cells Station 4L (26x16mm) Pass 1-2: Sampling performed ROSE: Similar atypical population Station 11R (22x13mm) Pass 1-2: Sampling performed ROSE: Atypical lymphoid proliferation Elastography used on Station 7 showing firm consistency (blue pattern) Airways: Bilaterally patent, no endobronchial lesions COMPLICATIONS: None SPECIMENS: \u2713 Cytology from all sampled stations \u2713 Flow cytometry - Stations 7, 4R, 4L, 11R \u2713 Cell blocks prepared \u2713 Cultures sent (Station 7) TOLERANCE: Procedure well tolerated, stable hemodynamics, O2 sats >95% throughout PRELIMINARY INTERPRETATION: EBUS-TBNA with ROSE findings highly suspicious for lymphoma involving multiple mediastinal and hilar stations (7, 4R, 4L, 11R). Extensive nodal involvement suggesting advanced stage. PLAN: 1.\tHematology-Oncology urgent consultation 2.\tFinal pathology with flow cytometry results in 3-5 days 3.\tStaging CT chest/abdomen/pelvis 4.\tBone marrow biopsy may be indicated 5.\tF/U IP clinic 1 week Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41 ________________________________________ EBUS", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "molecular_testing_requested": true, "disposition": "PACU Recovery", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["1.\tHematology-Oncology urgent consultation", "2.\tFinal pathology with flow cytometry results in 3-5 days", "3.\tStaging CT chest/abdomen/pelvis", "4.\tBone marrow biopsy may be indicated", "5.\tF/U IP clinic 1 week", "Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41", "________________________________________", "EBUS"], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": ["needle"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 136, "patient_identifier_trigger": "MR4729384", "field_name": "procedure_date", "gold_value": "2025-03-05", "predicted_value": "", "note_text": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)\nEndobronchial Ultrasound Bronchoscopy\nIndication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging\nPre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology\nAnesthesia: General anesthesia provided by anesthesia team (Dr. Martinez)\nEquipment: Pentax EB-1970UK linear EBUS scope\nProcedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination:\nLymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic\n\u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance\nTBNA sampling:\nStation 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified\nStation 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed\nStation 4L (24mm) 3 passes performed\nROSE: Malignant cells present\nStation 10R (18mm) 2 passes performed ROSE: Atypical cells\nProcedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition\nPreliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing\nPatient counseled post-procedure regarding findings\nNext steps: Oncology consult, PET-CT for full staging\nSigned: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15\n________________________________________\nEBUS\nBRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedu", "ground_truth_entry": {"patient_mrn": "MR4729384", "procedure_date": "2025-03-05", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 72, "gender": "Other", "asa_class": 3, "primary_indication": "Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Proc", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "patient_age": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "dob": "BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "Indication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Procedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination: Lymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic \u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance TBNA sampling: Station 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified Station 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed Station 4L (24mm) 3 passes performed ROSE: Malignant cells present Station 10R (18mm) 2 passes performed ROSE: Atypical cells Procedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition Preliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing Patient counseled post-procedure regarding findings Next steps: Oncology consult, PET-CT for full staging Signed: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15 ________________________________________ EBUS BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025 Provider: Elliott, Mark DO | Interventional Pulmonology INDICATION: Mediastinal lymphadenopathy, suspected lymphoma based on PET findings INFORMED CONSENT: Obtained, documented in chart PROCEDURE: EBUS-TBNA with ROSE ANESTHESIA: Conscious sedation - Fentanyl 100mcg IV, Midazolam 4mg IV Local - Lidocaine 4% spray, Lidocaine 2% 20cc via working channel EQUIPMENT: Olympus EBUS bronchoscope TECHNIQUE: EBUS scope introduced through mouth after adequate sedation. Vocal cords normal. Mediastinal ultrasound survey performed with following findings: Station 2R: Not enlarged Station 4R: 29mm, ABNORMAL - round, hypoechoic, loss of hilum Station 4L: 26mm, ABNORMAL - similar features Station 7: 47mm, MARKEDLY ABNORMAL - huge subcarinal node, diffuse hypoechoic pattern Station 10R: 14mm, mildly enlarged Station 10L: 19mm, enlarged Station 11R: 22mm, ABNORMAL appearance Station 11L: 20mm, ABNORMAL appearance SAMPLING DETAILS: Station 7 (47x29mm) - SUBCARINAL Pass 1: 22G needle, excellent tissue yield ROSE: Abundant large atypical lymphoid cells, HIGH SUSPICION for lymphoma Pass 2: Additional specimen for flow cytometry Pass 3: Additional specimen for flow cytometry Pass 4: Cell block preparation Station 4R (29x17mm) Pass 1-3: Consistent with Station 7 ROSE: Large atypical lymphoid cells Station 4L (26x16mm) Pass 1-2: Sampling performed ROSE: Similar atypical population Station 11R (22x13mm) Pass 1-2: Sampling performed ROSE: Atypical lymphoid proliferation Elastography used on Station 7 showing firm consistency (blue pattern) Airways: Bilaterally patent, no endobronchial lesions COMPLICATIONS: None SPECIMENS: \u2713 Cytology from all sampled stations \u2713 Flow cytometry - Stations 7, 4R, 4L, 11R \u2713 Cell blocks prepared \u2713 Cultures sent (Station 7) TOLERANCE: Procedure well tolerated, stable hemodynamics, O2 sats >95% throughout PRELIMINARY INTERPRETATION: EBUS-TBNA with ROSE findings highly suspicious for lymphoma involving multiple mediastinal and hilar stations (7, 4R, 4L, 11R). Extensive nodal involvement suggesting advanced stage. PLAN: 1.\tHematology-Oncology urgent consultation 2.\tFinal pathology with flow cytometry results in 3-5 days 3.\tStaging CT chest/abdomen/pelvis 4.\tBone marrow biopsy may be indicated 5.\tF/U IP clinic 1 week Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41 ________________________________________ EBUS", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "molecular_testing_requested": true, "disposition": "PACU Recovery", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["1.\tHematology-Oncology urgent consultation", "2.\tFinal pathology with flow cytometry results in 3-5 days", "3.\tStaging CT chest/abdomen/pelvis", "4.\tBone marrow biopsy may be indicated", "5.\tF/U IP clinic 1 week", "Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41", "________________________________________", "EBUS"], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": ["needle"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 136, "patient_identifier_trigger": "MR4729384", "field_name": "asa_class", "gold_value": "3", "predicted_value": "", "note_text": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)\nEndobronchial Ultrasound Bronchoscopy\nIndication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging\nPre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology\nAnesthesia: General anesthesia provided by anesthesia team (Dr. Martinez)\nEquipment: Pentax EB-1970UK linear EBUS scope\nProcedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination:\nLymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic\n\u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance\nTBNA sampling:\nStation 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified\nStation 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed\nStation 4L (24mm) 3 passes performed\nROSE: Malignant cells present\nStation 10R (18mm) 2 passes performed ROSE: Atypical cells\nProcedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition\nPreliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing\nPatient counseled post-procedure regarding findings\nNext steps: Oncology consult, PET-CT for full staging\nSigned: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15\n________________________________________\nEBUS\nBRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedu", "ground_truth_entry": {"patient_mrn": "MR4729384", "procedure_date": "2025-03-05", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 72, "gender": "Other", "asa_class": 3, "primary_indication": "Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Proc", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "patient_age": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "dob": "BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "Indication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Procedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination: Lymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic \u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance TBNA sampling: Station 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified Station 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed Station 4L (24mm) 3 passes performed ROSE: Malignant cells present Station 10R (18mm) 2 passes performed ROSE: Atypical cells Procedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition Preliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing Patient counseled post-procedure regarding findings Next steps: Oncology consult, PET-CT for full staging Signed: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15 ________________________________________ EBUS BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025 Provider: Elliott, Mark DO | Interventional Pulmonology INDICATION: Mediastinal lymphadenopathy, suspected lymphoma based on PET findings INFORMED CONSENT: Obtained, documented in chart PROCEDURE: EBUS-TBNA with ROSE ANESTHESIA: Conscious sedation - Fentanyl 100mcg IV, Midazolam 4mg IV Local - Lidocaine 4% spray, Lidocaine 2% 20cc via working channel EQUIPMENT: Olympus EBUS bronchoscope TECHNIQUE: EBUS scope introduced through mouth after adequate sedation. Vocal cords normal. Mediastinal ultrasound survey performed with following findings: Station 2R: Not enlarged Station 4R: 29mm, ABNORMAL - round, hypoechoic, loss of hilum Station 4L: 26mm, ABNORMAL - similar features Station 7: 47mm, MARKEDLY ABNORMAL - huge subcarinal node, diffuse hypoechoic pattern Station 10R: 14mm, mildly enlarged Station 10L: 19mm, enlarged Station 11R: 22mm, ABNORMAL appearance Station 11L: 20mm, ABNORMAL appearance SAMPLING DETAILS: Station 7 (47x29mm) - SUBCARINAL Pass 1: 22G needle, excellent tissue yield ROSE: Abundant large atypical lymphoid cells, HIGH SUSPICION for lymphoma Pass 2: Additional specimen for flow cytometry Pass 3: Additional specimen for flow cytometry Pass 4: Cell block preparation Station 4R (29x17mm) Pass 1-3: Consistent with Station 7 ROSE: Large atypical lymphoid cells Station 4L (26x16mm) Pass 1-2: Sampling performed ROSE: Similar atypical population Station 11R (22x13mm) Pass 1-2: Sampling performed ROSE: Atypical lymphoid proliferation Elastography used on Station 7 showing firm consistency (blue pattern) Airways: Bilaterally patent, no endobronchial lesions COMPLICATIONS: None SPECIMENS: \u2713 Cytology from all sampled stations \u2713 Flow cytometry - Stations 7, 4R, 4L, 11R \u2713 Cell blocks prepared \u2713 Cultures sent (Station 7) TOLERANCE: Procedure well tolerated, stable hemodynamics, O2 sats >95% throughout PRELIMINARY INTERPRETATION: EBUS-TBNA with ROSE findings highly suspicious for lymphoma involving multiple mediastinal and hilar stations (7, 4R, 4L, 11R). Extensive nodal involvement suggesting advanced stage. PLAN: 1.\tHematology-Oncology urgent consultation 2.\tFinal pathology with flow cytometry results in 3-5 days 3.\tStaging CT chest/abdomen/pelvis 4.\tBone marrow biopsy may be indicated 5.\tF/U IP clinic 1 week Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41 ________________________________________ EBUS", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "molecular_testing_requested": true, "disposition": "PACU Recovery", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["1.\tHematology-Oncology urgent consultation", "2.\tFinal pathology with flow cytometry results in 3-5 days", "3.\tStaging CT chest/abdomen/pelvis", "4.\tBone marrow biopsy may be indicated", "5.\tF/U IP clinic 1 week", "Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41", "________________________________________", "EBUS"], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": ["needle"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 136, "patient_identifier_trigger": "MR4729384", "field_name": "sedation_type", "gold_value": "general", "predicted_value": "", "note_text": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)\nEndobronchial Ultrasound Bronchoscopy\nIndication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging\nPre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology\nAnesthesia: General anesthesia provided by anesthesia team (Dr. Martinez)\nEquipment: Pentax EB-1970UK linear EBUS scope\nProcedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination:\nLymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic\n\u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance\nTBNA sampling:\nStation 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified\nStation 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed\nStation 4L (24mm) 3 passes performed\nROSE: Malignant cells present\nStation 10R (18mm) 2 passes performed ROSE: Atypical cells\nProcedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition\nPreliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing\nPatient counseled post-procedure regarding findings\nNext steps: Oncology consult, PET-CT for full staging\nSigned: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15\n________________________________________\nEBUS\nBRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedu", "ground_truth_entry": {"patient_mrn": "MR4729384", "procedure_date": "2025-03-05", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 72, "gender": "Other", "asa_class": 3, "primary_indication": "Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Proc", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "patient_age": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "dob": "BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "Indication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Procedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination: Lymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic \u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance TBNA sampling: Station 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified Station 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed Station 4L (24mm) 3 passes performed ROSE: Malignant cells present Station 10R (18mm) 2 passes performed ROSE: Atypical cells Procedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition Preliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing Patient counseled post-procedure regarding findings Next steps: Oncology consult, PET-CT for full staging Signed: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15 ________________________________________ EBUS BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025 Provider: Elliott, Mark DO | Interventional Pulmonology INDICATION: Mediastinal lymphadenopathy, suspected lymphoma based on PET findings INFORMED CONSENT: Obtained, documented in chart PROCEDURE: EBUS-TBNA with ROSE ANESTHESIA: Conscious sedation - Fentanyl 100mcg IV, Midazolam 4mg IV Local - Lidocaine 4% spray, Lidocaine 2% 20cc via working channel EQUIPMENT: Olympus EBUS bronchoscope TECHNIQUE: EBUS scope introduced through mouth after adequate sedation. Vocal cords normal. Mediastinal ultrasound survey performed with following findings: Station 2R: Not enlarged Station 4R: 29mm, ABNORMAL - round, hypoechoic, loss of hilum Station 4L: 26mm, ABNORMAL - similar features Station 7: 47mm, MARKEDLY ABNORMAL - huge subcarinal node, diffuse hypoechoic pattern Station 10R: 14mm, mildly enlarged Station 10L: 19mm, enlarged Station 11R: 22mm, ABNORMAL appearance Station 11L: 20mm, ABNORMAL appearance SAMPLING DETAILS: Station 7 (47x29mm) - SUBCARINAL Pass 1: 22G needle, excellent tissue yield ROSE: Abundant large atypical lymphoid cells, HIGH SUSPICION for lymphoma Pass 2: Additional specimen for flow cytometry Pass 3: Additional specimen for flow cytometry Pass 4: Cell block preparation Station 4R (29x17mm) Pass 1-3: Consistent with Station 7 ROSE: Large atypical lymphoid cells Station 4L (26x16mm) Pass 1-2: Sampling performed ROSE: Similar atypical population Station 11R (22x13mm) Pass 1-2: Sampling performed ROSE: Atypical lymphoid proliferation Elastography used on Station 7 showing firm consistency (blue pattern) Airways: Bilaterally patent, no endobronchial lesions COMPLICATIONS: None SPECIMENS: \u2713 Cytology from all sampled stations \u2713 Flow cytometry - Stations 7, 4R, 4L, 11R \u2713 Cell blocks prepared \u2713 Cultures sent (Station 7) TOLERANCE: Procedure well tolerated, stable hemodynamics, O2 sats >95% throughout PRELIMINARY INTERPRETATION: EBUS-TBNA with ROSE findings highly suspicious for lymphoma involving multiple mediastinal and hilar stations (7, 4R, 4L, 11R). Extensive nodal involvement suggesting advanced stage. PLAN: 1.\tHematology-Oncology urgent consultation 2.\tFinal pathology with flow cytometry results in 3-5 days 3.\tStaging CT chest/abdomen/pelvis 4.\tBone marrow biopsy may be indicated 5.\tF/U IP clinic 1 week Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41 ________________________________________ EBUS", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "molecular_testing_requested": true, "disposition": "PACU Recovery", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["1.\tHematology-Oncology urgent consultation", "2.\tFinal pathology with flow cytometry results in 3-5 days", "3.\tStaging CT chest/abdomen/pelvis", "4.\tBone marrow biopsy may be indicated", "5.\tF/U IP clinic 1 week", "Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41", "________________________________________", "EBUS"], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": ["needle"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 136, "patient_identifier_trigger": "MR4729384", "field_name": "airway_type", "gold_value": "ett", "predicted_value": "", "note_text": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)\nEndobronchial Ultrasound Bronchoscopy\nIndication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging\nPre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology\nAnesthesia: General anesthesia provided by anesthesia team (Dr. Martinez)\nEquipment: Pentax EB-1970UK linear EBUS scope\nProcedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination:\nLymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic\n\u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance\nTBNA sampling:\nStation 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified\nStation 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed\nStation 4L (24mm) 3 passes performed\nROSE: Malignant cells present\nStation 10R (18mm) 2 passes performed ROSE: Atypical cells\nProcedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition\nPreliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing\nPatient counseled post-procedure regarding findings\nNext steps: Oncology consult, PET-CT for full staging\nSigned: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15\n________________________________________\nEBUS\nBRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedu", "ground_truth_entry": {"patient_mrn": "MR4729384", "procedure_date": "2025-03-05", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 72, "gender": "Other", "asa_class": 3, "primary_indication": "Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Proc", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "patient_age": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "dob": "BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "Indication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Procedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination: Lymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic \u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance TBNA sampling: Station 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified Station 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed Station 4L (24mm) 3 passes performed ROSE: Malignant cells present Station 10R (18mm) 2 passes performed ROSE: Atypical cells Procedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition Preliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing Patient counseled post-procedure regarding findings Next steps: Oncology consult, PET-CT for full staging Signed: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15 ________________________________________ EBUS BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025 Provider: Elliott, Mark DO | Interventional Pulmonology INDICATION: Mediastinal lymphadenopathy, suspected lymphoma based on PET findings INFORMED CONSENT: Obtained, documented in chart PROCEDURE: EBUS-TBNA with ROSE ANESTHESIA: Conscious sedation - Fentanyl 100mcg IV, Midazolam 4mg IV Local - Lidocaine 4% spray, Lidocaine 2% 20cc via working channel EQUIPMENT: Olympus EBUS bronchoscope TECHNIQUE: EBUS scope introduced through mouth after adequate sedation. Vocal cords normal. Mediastinal ultrasound survey performed with following findings: Station 2R: Not enlarged Station 4R: 29mm, ABNORMAL - round, hypoechoic, loss of hilum Station 4L: 26mm, ABNORMAL - similar features Station 7: 47mm, MARKEDLY ABNORMAL - huge subcarinal node, diffuse hypoechoic pattern Station 10R: 14mm, mildly enlarged Station 10L: 19mm, enlarged Station 11R: 22mm, ABNORMAL appearance Station 11L: 20mm, ABNORMAL appearance SAMPLING DETAILS: Station 7 (47x29mm) - SUBCARINAL Pass 1: 22G needle, excellent tissue yield ROSE: Abundant large atypical lymphoid cells, HIGH SUSPICION for lymphoma Pass 2: Additional specimen for flow cytometry Pass 3: Additional specimen for flow cytometry Pass 4: Cell block preparation Station 4R (29x17mm) Pass 1-3: Consistent with Station 7 ROSE: Large atypical lymphoid cells Station 4L (26x16mm) Pass 1-2: Sampling performed ROSE: Similar atypical population Station 11R (22x13mm) Pass 1-2: Sampling performed ROSE: Atypical lymphoid proliferation Elastography used on Station 7 showing firm consistency (blue pattern) Airways: Bilaterally patent, no endobronchial lesions COMPLICATIONS: None SPECIMENS: \u2713 Cytology from all sampled stations \u2713 Flow cytometry - Stations 7, 4R, 4L, 11R \u2713 Cell blocks prepared \u2713 Cultures sent (Station 7) TOLERANCE: Procedure well tolerated, stable hemodynamics, O2 sats >95% throughout PRELIMINARY INTERPRETATION: EBUS-TBNA with ROSE findings highly suspicious for lymphoma involving multiple mediastinal and hilar stations (7, 4R, 4L, 11R). Extensive nodal involvement suggesting advanced stage. PLAN: 1.\tHematology-Oncology urgent consultation 2.\tFinal pathology with flow cytometry results in 3-5 days 3.\tStaging CT chest/abdomen/pelvis 4.\tBone marrow biopsy may be indicated 5.\tF/U IP clinic 1 week Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41 ________________________________________ EBUS", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "molecular_testing_requested": true, "disposition": "PACU Recovery", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["1.\tHematology-Oncology urgent consultation", "2.\tFinal pathology with flow cytometry results in 3-5 days", "3.\tStaging CT chest/abdomen/pelvis", "4.\tBone marrow biopsy may be indicated", "5.\tF/U IP clinic 1 week", "Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41", "________________________________________", "EBUS"], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": ["needle"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 136, "patient_identifier_trigger": "MR4729384", "field_name": "final_diagnosis_prelim", "gold_value": "malignancy", "predicted_value": "", "note_text": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)\nEndobronchial Ultrasound Bronchoscopy\nIndication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging\nPre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology\nAnesthesia: General anesthesia provided by anesthesia team (Dr. Martinez)\nEquipment: Pentax EB-1970UK linear EBUS scope\nProcedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination:\nLymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic\n\u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance\nTBNA sampling:\nStation 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified\nStation 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed\nStation 4L (24mm) 3 passes performed\nROSE: Malignant cells present\nStation 10R (18mm) 2 passes performed ROSE: Atypical cells\nProcedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition\nPreliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing\nPatient counseled post-procedure regarding findings\nNext steps: Oncology consult, PET-CT for full staging\nSigned: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15\n________________________________________\nEBUS\nBRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedu", "ground_truth_entry": {"patient_mrn": "MR4729384", "procedure_date": "2025-03-05", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 72, "gender": "Other", "asa_class": 3, "primary_indication": "Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Proc", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "patient_age": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "dob": "BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "Indication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Procedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination: Lymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic \u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance TBNA sampling: Station 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified Station 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed Station 4L (24mm) 3 passes performed ROSE: Malignant cells present Station 10R (18mm) 2 passes performed ROSE: Atypical cells Procedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition Preliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing Patient counseled post-procedure regarding findings Next steps: Oncology consult, PET-CT for full staging Signed: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15 ________________________________________ EBUS BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025 Provider: Elliott, Mark DO | Interventional Pulmonology INDICATION: Mediastinal lymphadenopathy, suspected lymphoma based on PET findings INFORMED CONSENT: Obtained, documented in chart PROCEDURE: EBUS-TBNA with ROSE ANESTHESIA: Conscious sedation - Fentanyl 100mcg IV, Midazolam 4mg IV Local - Lidocaine 4% spray, Lidocaine 2% 20cc via working channel EQUIPMENT: Olympus EBUS bronchoscope TECHNIQUE: EBUS scope introduced through mouth after adequate sedation. Vocal cords normal. Mediastinal ultrasound survey performed with following findings: Station 2R: Not enlarged Station 4R: 29mm, ABNORMAL - round, hypoechoic, loss of hilum Station 4L: 26mm, ABNORMAL - similar features Station 7: 47mm, MARKEDLY ABNORMAL - huge subcarinal node, diffuse hypoechoic pattern Station 10R: 14mm, mildly enlarged Station 10L: 19mm, enlarged Station 11R: 22mm, ABNORMAL appearance Station 11L: 20mm, ABNORMAL appearance SAMPLING DETAILS: Station 7 (47x29mm) - SUBCARINAL Pass 1: 22G needle, excellent tissue yield ROSE: Abundant large atypical lymphoid cells, HIGH SUSPICION for lymphoma Pass 2: Additional specimen for flow cytometry Pass 3: Additional specimen for flow cytometry Pass 4: Cell block preparation Station 4R (29x17mm) Pass 1-3: Consistent with Station 7 ROSE: Large atypical lymphoid cells Station 4L (26x16mm) Pass 1-2: Sampling performed ROSE: Similar atypical population Station 11R (22x13mm) Pass 1-2: Sampling performed ROSE: Atypical lymphoid proliferation Elastography used on Station 7 showing firm consistency (blue pattern) Airways: Bilaterally patent, no endobronchial lesions COMPLICATIONS: None SPECIMENS: \u2713 Cytology from all sampled stations \u2713 Flow cytometry - Stations 7, 4R, 4L, 11R \u2713 Cell blocks prepared \u2713 Cultures sent (Station 7) TOLERANCE: Procedure well tolerated, stable hemodynamics, O2 sats >95% throughout PRELIMINARY INTERPRETATION: EBUS-TBNA with ROSE findings highly suspicious for lymphoma involving multiple mediastinal and hilar stations (7, 4R, 4L, 11R). Extensive nodal involvement suggesting advanced stage. PLAN: 1.\tHematology-Oncology urgent consultation 2.\tFinal pathology with flow cytometry results in 3-5 days 3.\tStaging CT chest/abdomen/pelvis 4.\tBone marrow biopsy may be indicated 5.\tF/U IP clinic 1 week Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41 ________________________________________ EBUS", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "molecular_testing_requested": true, "disposition": "PACU Recovery", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["1.\tHematology-Oncology urgent consultation", "2.\tFinal pathology with flow cytometry results in 3-5 days", "3.\tStaging CT chest/abdomen/pelvis", "4.\tBone marrow biopsy may be indicated", "5.\tF/U IP clinic 1 week", "Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41", "________________________________________", "EBUS"], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": ["needle"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 136, "patient_identifier_trigger": "MR4729384", "field_name": "disposition", "gold_value": "pacu recovery", "predicted_value": "", "note_text": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)\nEndobronchial Ultrasound Bronchoscopy\nIndication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging\nPre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology\nAnesthesia: General anesthesia provided by anesthesia team (Dr. Martinez)\nEquipment: Pentax EB-1970UK linear EBUS scope\nProcedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination:\nLymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic\n\u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance\nTBNA sampling:\nStation 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified\nStation 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed\nStation 4L (24mm) 3 passes performed\nROSE: Malignant cells present\nStation 10R (18mm) 2 passes performed ROSE: Atypical cells\nProcedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition\nPreliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing\nPatient counseled post-procedure regarding findings\nNext steps: Oncology consult, PET-CT for full staging\nSigned: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15\n________________________________________\nEBUS\nBRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedu", "ground_truth_entry": {"patient_mrn": "MR4729384", "procedure_date": "2025-03-05", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 72, "gender": "Other", "asa_class": 3, "primary_indication": "Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Proc", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "patient_age": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "dob": "BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "Indication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Procedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination: Lymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic \u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance TBNA sampling: Station 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified Station 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed Station 4L (24mm) 3 passes performed ROSE: Malignant cells present Station 10R (18mm) 2 passes performed ROSE: Atypical cells Procedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition Preliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing Patient counseled post-procedure regarding findings Next steps: Oncology consult, PET-CT for full staging Signed: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15 ________________________________________ EBUS BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025 Provider: Elliott, Mark DO | Interventional Pulmonology INDICATION: Mediastinal lymphadenopathy, suspected lymphoma based on PET findings INFORMED CONSENT: Obtained, documented in chart PROCEDURE: EBUS-TBNA with ROSE ANESTHESIA: Conscious sedation - Fentanyl 100mcg IV, Midazolam 4mg IV Local - Lidocaine 4% spray, Lidocaine 2% 20cc via working channel EQUIPMENT: Olympus EBUS bronchoscope TECHNIQUE: EBUS scope introduced through mouth after adequate sedation. Vocal cords normal. Mediastinal ultrasound survey performed with following findings: Station 2R: Not enlarged Station 4R: 29mm, ABNORMAL - round, hypoechoic, loss of hilum Station 4L: 26mm, ABNORMAL - similar features Station 7: 47mm, MARKEDLY ABNORMAL - huge subcarinal node, diffuse hypoechoic pattern Station 10R: 14mm, mildly enlarged Station 10L: 19mm, enlarged Station 11R: 22mm, ABNORMAL appearance Station 11L: 20mm, ABNORMAL appearance SAMPLING DETAILS: Station 7 (47x29mm) - SUBCARINAL Pass 1: 22G needle, excellent tissue yield ROSE: Abundant large atypical lymphoid cells, HIGH SUSPICION for lymphoma Pass 2: Additional specimen for flow cytometry Pass 3: Additional specimen for flow cytometry Pass 4: Cell block preparation Station 4R (29x17mm) Pass 1-3: Consistent with Station 7 ROSE: Large atypical lymphoid cells Station 4L (26x16mm) Pass 1-2: Sampling performed ROSE: Similar atypical population Station 11R (22x13mm) Pass 1-2: Sampling performed ROSE: Atypical lymphoid proliferation Elastography used on Station 7 showing firm consistency (blue pattern) Airways: Bilaterally patent, no endobronchial lesions COMPLICATIONS: None SPECIMENS: \u2713 Cytology from all sampled stations \u2713 Flow cytometry - Stations 7, 4R, 4L, 11R \u2713 Cell blocks prepared \u2713 Cultures sent (Station 7) TOLERANCE: Procedure well tolerated, stable hemodynamics, O2 sats >95% throughout PRELIMINARY INTERPRETATION: EBUS-TBNA with ROSE findings highly suspicious for lymphoma involving multiple mediastinal and hilar stations (7, 4R, 4L, 11R). Extensive nodal involvement suggesting advanced stage. PLAN: 1.\tHematology-Oncology urgent consultation 2.\tFinal pathology with flow cytometry results in 3-5 days 3.\tStaging CT chest/abdomen/pelvis 4.\tBone marrow biopsy may be indicated 5.\tF/U IP clinic 1 week Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41 ________________________________________ EBUS", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "molecular_testing_requested": true, "disposition": "PACU Recovery", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["1.\tHematology-Oncology urgent consultation", "2.\tFinal pathology with flow cytometry results in 3-5 days", "3.\tStaging CT chest/abdomen/pelvis", "4.\tBone marrow biopsy may be indicated", "5.\tF/U IP clinic 1 week", "Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41", "________________________________________", "EBUS"], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": ["needle"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 137, "patient_identifier_trigger": "MR4729384", "field_name": "patient_mrn", "gold_value": "mr4729384", "predicted_value": "8362719", "note_text": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)\nEndobronchial Ultrasound Bronchoscopy\nIndication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging\nPre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology\nAnesthesia: General anesthesia provided by anesthesia team (Dr. Martinez)\nEquipment: Pentax EB-1970UK linear EBUS scope\nProcedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination:\nLymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic\n\u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance\nTBNA sampling:\nStation 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified\nStation 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed\nStation 4L (24mm) 3 passes performed\nROSE: Malignant cells present\nStation 10R (18mm) 2 passes performed ROSE: Atypical cells\nProcedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition\nPreliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing\nPatient counseled post-procedure regarding findings\nNext steps: Oncology consult, PET-CT for full staging\nSigned: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15\n________________________________________\n\nBRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: ", "ground_truth_entry": {"patient_mrn": "MR4729384", "procedure_date": "2025-03-05", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 72, "gender": "Other", "asa_class": 3, "primary_indication": "Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Proc", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "patient_age": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "dob": "BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "Indication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Procedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination: Lymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic \u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance TBNA sampling: Station 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified Station 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed Station 4L (24mm) 3 passes performed ROSE: Malignant cells present Station 10R (18mm) 2 passes performed ROSE: Atypical cells Procedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition Preliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing Patient counseled post-procedure regarding findings Next steps: Oncology consult, PET-CT for full staging Signed: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15 ________________________________________", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "molecular_testing_requested": true, "disposition": "PACU Recovery", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["6.\tHematology-Oncology urgent consultation", "7.\tFinal pathology with flow cytometry results in 3-5 days", "8.\tStaging CT chest/abdomen/pelvis", "9.\tBone marrow biopsy may be indicated", "10.\tF/U IP clinic 1 week", "Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41", "________________________________________"], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": ["needle"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 137, "patient_identifier_trigger": "MR4729384", "field_name": "procedure_date", "gold_value": "2025-03-05", "predicted_value": "", "note_text": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)\nEndobronchial Ultrasound Bronchoscopy\nIndication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging\nPre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology\nAnesthesia: General anesthesia provided by anesthesia team (Dr. Martinez)\nEquipment: Pentax EB-1970UK linear EBUS scope\nProcedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination:\nLymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic\n\u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance\nTBNA sampling:\nStation 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified\nStation 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed\nStation 4L (24mm) 3 passes performed\nROSE: Malignant cells present\nStation 10R (18mm) 2 passes performed ROSE: Atypical cells\nProcedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition\nPreliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing\nPatient counseled post-procedure regarding findings\nNext steps: Oncology consult, PET-CT for full staging\nSigned: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15\n________________________________________\n\nBRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: ", "ground_truth_entry": {"patient_mrn": "MR4729384", "procedure_date": "2025-03-05", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 72, "gender": "Other", "asa_class": 3, "primary_indication": "Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Proc", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "patient_age": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "dob": "BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "Indication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Procedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination: Lymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic \u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance TBNA sampling: Station 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified Station 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed Station 4L (24mm) 3 passes performed ROSE: Malignant cells present Station 10R (18mm) 2 passes performed ROSE: Atypical cells Procedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition Preliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing Patient counseled post-procedure regarding findings Next steps: Oncology consult, PET-CT for full staging Signed: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15 ________________________________________", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "molecular_testing_requested": true, "disposition": "PACU Recovery", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["6.\tHematology-Oncology urgent consultation", "7.\tFinal pathology with flow cytometry results in 3-5 days", "8.\tStaging CT chest/abdomen/pelvis", "9.\tBone marrow biopsy may be indicated", "10.\tF/U IP clinic 1 week", "Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41", "________________________________________"], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": ["needle"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 137, "patient_identifier_trigger": "MR4729384", "field_name": "asa_class", "gold_value": "3", "predicted_value": "", "note_text": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)\nEndobronchial Ultrasound Bronchoscopy\nIndication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging\nPre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology\nAnesthesia: General anesthesia provided by anesthesia team (Dr. Martinez)\nEquipment: Pentax EB-1970UK linear EBUS scope\nProcedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination:\nLymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic\n\u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance\nTBNA sampling:\nStation 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified\nStation 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed\nStation 4L (24mm) 3 passes performed\nROSE: Malignant cells present\nStation 10R (18mm) 2 passes performed ROSE: Atypical cells\nProcedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition\nPreliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing\nPatient counseled post-procedure regarding findings\nNext steps: Oncology consult, PET-CT for full staging\nSigned: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15\n________________________________________\n\nBRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: ", "ground_truth_entry": {"patient_mrn": "MR4729384", "procedure_date": "2025-03-05", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 72, "gender": "Other", "asa_class": 3, "primary_indication": "Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Proc", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "patient_age": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "dob": "BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "Indication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Procedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination: Lymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic \u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance TBNA sampling: Station 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified Station 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed Station 4L (24mm) 3 passes performed ROSE: Malignant cells present Station 10R (18mm) 2 passes performed ROSE: Atypical cells Procedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition Preliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing Patient counseled post-procedure regarding findings Next steps: Oncology consult, PET-CT for full staging Signed: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15 ________________________________________", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "molecular_testing_requested": true, "disposition": "PACU Recovery", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["6.\tHematology-Oncology urgent consultation", "7.\tFinal pathology with flow cytometry results in 3-5 days", "8.\tStaging CT chest/abdomen/pelvis", "9.\tBone marrow biopsy may be indicated", "10.\tF/U IP clinic 1 week", "Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41", "________________________________________"], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": ["needle"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 137, "patient_identifier_trigger": "MR4729384", "field_name": "sedation_type", "gold_value": "general", "predicted_value": "", "note_text": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)\nEndobronchial Ultrasound Bronchoscopy\nIndication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging\nPre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology\nAnesthesia: General anesthesia provided by anesthesia team (Dr. Martinez)\nEquipment: Pentax EB-1970UK linear EBUS scope\nProcedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination:\nLymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic\n\u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance\nTBNA sampling:\nStation 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified\nStation 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed\nStation 4L (24mm) 3 passes performed\nROSE: Malignant cells present\nStation 10R (18mm) 2 passes performed ROSE: Atypical cells\nProcedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition\nPreliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing\nPatient counseled post-procedure regarding findings\nNext steps: Oncology consult, PET-CT for full staging\nSigned: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15\n________________________________________\n\nBRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: ", "ground_truth_entry": {"patient_mrn": "MR4729384", "procedure_date": "2025-03-05", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 72, "gender": "Other", "asa_class": 3, "primary_indication": "Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Proc", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "patient_age": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "dob": "BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "Indication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Procedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination: Lymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic \u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance TBNA sampling: Station 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified Station 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed Station 4L (24mm) 3 passes performed ROSE: Malignant cells present Station 10R (18mm) 2 passes performed ROSE: Atypical cells Procedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition Preliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing Patient counseled post-procedure regarding findings Next steps: Oncology consult, PET-CT for full staging Signed: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15 ________________________________________", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "molecular_testing_requested": true, "disposition": "PACU Recovery", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["6.\tHematology-Oncology urgent consultation", "7.\tFinal pathology with flow cytometry results in 3-5 days", "8.\tStaging CT chest/abdomen/pelvis", "9.\tBone marrow biopsy may be indicated", "10.\tF/U IP clinic 1 week", "Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41", "________________________________________"], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": ["needle"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 137, "patient_identifier_trigger": "MR4729384", "field_name": "airway_type", "gold_value": "ett", "predicted_value": "", "note_text": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)\nEndobronchial Ultrasound Bronchoscopy\nIndication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging\nPre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology\nAnesthesia: General anesthesia provided by anesthesia team (Dr. Martinez)\nEquipment: Pentax EB-1970UK linear EBUS scope\nProcedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination:\nLymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic\n\u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance\nTBNA sampling:\nStation 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified\nStation 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed\nStation 4L (24mm) 3 passes performed\nROSE: Malignant cells present\nStation 10R (18mm) 2 passes performed ROSE: Atypical cells\nProcedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition\nPreliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing\nPatient counseled post-procedure regarding findings\nNext steps: Oncology consult, PET-CT for full staging\nSigned: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15\n________________________________________\n\nBRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: ", "ground_truth_entry": {"patient_mrn": "MR4729384", "procedure_date": "2025-03-05", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 72, "gender": "Other", "asa_class": 3, "primary_indication": "Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Proc", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "patient_age": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "dob": "BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "Indication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Procedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination: Lymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic \u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance TBNA sampling: Station 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified Station 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed Station 4L (24mm) 3 passes performed ROSE: Malignant cells present Station 10R (18mm) 2 passes performed ROSE: Atypical cells Procedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition Preliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing Patient counseled post-procedure regarding findings Next steps: Oncology consult, PET-CT for full staging Signed: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15 ________________________________________", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "molecular_testing_requested": true, "disposition": "PACU Recovery", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["6.\tHematology-Oncology urgent consultation", "7.\tFinal pathology with flow cytometry results in 3-5 days", "8.\tStaging CT chest/abdomen/pelvis", "9.\tBone marrow biopsy may be indicated", "10.\tF/U IP clinic 1 week", "Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41", "________________________________________"], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": ["needle"], "nav_cryobiopsy_for_nodule": null}}
{"example_index": 137, "patient_identifier_trigger": "MR4729384", "field_name": "final_diagnosis_prelim", "gold_value": "malignancy", "predicted_value": "", "note_text": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)\nEndobronchial Ultrasound Bronchoscopy\nIndication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging\nPre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology\nAnesthesia: General anesthesia provided by anesthesia team (Dr. Martinez)\nEquipment: Pentax EB-1970UK linear EBUS scope\nProcedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination:\nLymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic\n\u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance\nTBNA sampling:\nStation 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified\nStation 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed\nStation 4L (24mm) 3 passes performed\nROSE: Malignant cells present\nStation 10R (18mm) 2 passes performed ROSE: Atypical cells\nProcedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition\nPreliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing\nPatient counseled post-procedure regarding findings\nNext steps: Oncology consult, PET-CT for full staging\nSigned: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15\n________________________________________\n\nBRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: ", "ground_truth_entry": {"patient_mrn": "MR4729384", "procedure_date": "2025-03-05", "provider_role": "Attending", "attending_name": "Unknown", "patient_age": 72, "gender": "Other", "asa_class": 3, "primary_indication": "Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Proc", "sedation_type": "General", "airway_type": "ETT", "final_diagnosis_prelim": "Malignancy", "data_entry_status": "Complete", "version": "0.4.0", "cpt_codes": [31653], "evidence": {"procedure_date": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "patient_age": "Patient: Moore, Christopher | ID: MR4729384 | Age: 72 | M Service Date: 03/05/2025 | Start Time: 0745 Physician: Dr. Patel, Anjali (Attending) | Dr. Kim, Susan (Fellow)", "dob": "BRONCHOSCOPY PROCEDURE DOCUMENTATION Patient: Clark, Sandra M | MRN 8362719 | DOB 04/15/1968 Date of Procedure: 02/22/2025", "asa_class": "Defaulted to ASA 3 (not explicitly documented)", "primary_indication": "Indication: Small cell lung cancer staging, enlarged mediastinal lymph nodes on imaging Pre-op diagnosis: Small cell lung cancer, clinical stage Post-op diagnosis: Pending final pathology Anesthesia: General anesthesia provided by anesthesia team (Dr. Martinez) Equipment: Pentax EB-1970UK linear EBUS scope Procedure narrative: After successful intubation and adequate depth of anesthesia, timeout performed. EBUS bronchoscope inserted via ETT. Initial inspection showed normal trachea, sharp carina. Systematic ultrasound examination: Lymph node stations evaluated: \u2192 2R: 11mm, normal echogenicity \u2192 4R: 31mm, ENLARGED, loss of normal architecture \u2192 4L: 24mm, ENLARGED, hypoechoic \u2192 7: 42mm, MARKEDLY ENLARGED, heterogeneous \u2192 10R: 18mm, prominent \u2192 10L: 16mm, prominent \u2192 11R: 21mm, abnormal appearance TBNA sampling: Station 7 (42mm) Needle: 22G Pass 1 @ 0758 - visible tissue core Pass 2 @ 0801 - additional sample Pass 3 @ 0803 - for molecular studies Pass 4 @ 0805 - microbiology ROSE Result: MALIGNANT, small cell morphology identified Station 4R (31mm) 3 passes performed ROSE: Small cell carcinoma confirmed Station 4L (24mm) 3 passes performed ROSE: Malignant cells present Station 10R (18mm) 2 passes performed ROSE: Atypical cells Procedure completed 0822 Total time: 37 minutes EBL: <5mL Patient extubated, to recovery in stable condition Preliminary findings: Extensive N2/N3 disease confirmed Specimens to pathology: Cytology, cell block, molecular testing Patient counseled post-procedure regarding findings Next steps: Oncology consult, PET-CT for full staging Signed: Dr. Anjali Pat tel, MD, FCCP Time: 03/05/2025 09:15 ________________________________________", "sedation_type": "general anesthesia/GA context", "airway_type": "ETT mentioned or implied"}, "molecular_testing_requested": true, "disposition": "PACU Recovery", "bleeding_severity": "None/Scant", "pneumothorax": false, "pneumothorax_intervention": "None", "ablation_peripheral_performed": false, "ablation_modality": null, "pleural_procedure_type": null, "pleural_guidance": null, "pleurodesis_performed": false, "pleurodesis_agent": null, "blvr_target_lobe": null, "blvr_valve_type": null, "blvr_number_of_valves": null, "wll_volume_instilled_l": null, "wll_volume_returned_l": null, "wll_dlt_used": null, "fb_object_type": null, "fb_tool_used": [], "fb_removal_success": null, "bt_lobe_treated": null, "bt_activation_count": null, "follow_up_plan": ["6.\tHematology-Oncology urgent consultation", "7.\tFinal pathology with flow cytometry results in 3-5 days", "8.\tStaging CT chest/abdomen/pelvis", "9.\tBone marrow biopsy may be indicated", "10.\tF/U IP clinic 1 week", "Mark Elliott, DO Interventional Pulmonology Signed: 02/22/2025 15:41", "________________________________________"], "nav_platform": null, "nav_registration_method": null, "nav_registration_error_mm": null, "nav_rebus_used": null, "nav_rebus_view": null, "nav_imaging_verification": null, "nav_tool_in_lesion": null, "nav_sampling_tools": ["needle"], "nav_cryobiopsy_for_nodule": null}}
